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Abstract 
Colorants are added to food items to give consumers the appetizing and 
attractive qualities they desire. Caramel, a brown food colorant, has been widely 
used in food industries. Studies indicated that ammonia (Class III) caramel may 
have undesirable effects on the immune system of the experimental animals. The 
consumers' concern on the safety of synthetic food additives remains and the demand 
for natural pigments as food colorants increases. 
In this research, a natural brown pigment was prepared from the Chinese 
chestnut {Cast am a mollissimd) shells. This Castanea. pigment (CP) preparation 
was shown to be stable at autoclaving temperature (121°C). Its color remained 
unchanged after a 12-month test period under normal room light condition. The CP 
was also found to possess antioxidative activity. 
The Microtox® test indicated that the toxicity of the crude CP was very low 
(EC50 = 360 ppm). The toxicity was further reduced by subsequent purification 
procedures including organic solvent extraction (EC50 = 650 ppm). The 
mutagenicity of CP was assessed by the Mutatox® test. Results showed that CP was 
not a suspected mutagen. 
For the safety evaluation of CP, its toxicity was further assessed using the 
experimental animal model. CP dissolved in distilled water was provided for 
drinking ad libitum to male Sprague-Dawley (SD) rats. An acute toxicity test was 
run for 14 days with 0 and 8% CP, while the chronic tests were run for 6 months and 
9 months with 0，0.25 and 1% CP. Physical parameters including the body weight 
gains, food and fluid consumptions were recorded during the course of the 
experiment. Clinical analysis including haematology，blood chemistry and 
i 
urinalysis were done. Histopathological examination was performed for organs 
including kidney, liver and thymus, also testis for the chronic test. All rats tolerated 
these doses of CP well. No adverse effect was found in the acute test except an 
increase in the caecal content and reductions in serum aspartate aminotransferase 
(AST) and y-glutamyl transpeptidase (GGTP) levels were observed in treated rats. 
In the chronic test, no rats treated with CP showed any clinical signs of toxicity. 









顯 示 板 栗 色 素 在 高 壓 反 應 器 下 保 持 穩 定 。 經 過 十 二 個 月 的 室 
溫光線存放下，它的顏色仍維持不變。此外，板栗色素具有抗氧化 
活性。 
在Microtox®測試中，粗製的色素毒性很低(EC50 = 360 ppm) ,而 




鼠不斷食用。一項急性毒性測試進行為期十四天，採用 0 %和 8 %濃 
度的板栗色素；而慢性毒性測試則進行為期六個月和九個月，採用 
0 % � 0 . 2 5 % 和 1 % 濃度的板栗色素。基本因素包括體重增加、食糧 
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Introduction 
Chapter 1 Introduction 
1.1 Food colorants 
Colorants have been used to make food more attractive and appetizing for 
centuries. It is often the first sensory quality by which foods are judged. Similarly, 
both food quality and flavor are associated with color. Our senses are trained to 
expect foods of certain colors and reject any deviations from our expectations. 
Foods that are aesthetically pleasing are more likely to be consumed, thereby 
contributing to a variety of diet and, hence, better nutrition. 
Both synthetic and natural food colorants are used. They play a significant 
role in enhancing the aesthetic appeal of processed foods. Also, they are important 
ingredients in many convenience foods such as confectionery, instant desserts, 
ice-creams, snacks, and beverages, since many of these are naturally colorless. 
Colors are used to supplement the natural appearance of a given food system and to 
ensure batch-to-batch uniformity where raw materials have varying color intensities. 
However, more and more synthetic food colorants have been proven to be 
toxic. Table 1.1 lists the synthetic colorants which were banned in the United States 
since 1950s (Ghorpade et al, 1994). For example, Amaranth, which was first used 
in 1907, was banned in 1976. It has been misused for about seventy years. This 
provides a message that synthetic food colorants which are considered safe now, may 
not be safe any more in the future. There are now only seven dyes that have been 
approved by the Food and Drug Administration (FDA) for safe use in food, drugs 
and cosmetics. These are known as FD&C dyes. These dyes are Yellows #5 and 
#6, Reds #3 and #40，Blues #\ and #2，and Green #3. The most popular of these 
dyes is Red #40. The second most popular is Yellow #5 (Ghorpade et al., 1994). 
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Table 1.1 Synthetic food colorants banned in the United States. 
Common name FDA name Year listed for Year delisted Current status 
food use for food use 
Ponceau 3R FD&C Red I W N ^ 
No.l allowed 
~~Amaranth FD&C Red WJ6 N ^ 
NO.2 allowed 
~~Orange 1 FD&C Orange ^ 
No.l allowed 
Naphthol FD&C Yellow f o ^ [ 9 ^ ^ 
Yellow S No.l allowed 
Light Green S D F D & C Green f ^ ^ 
Yellowish No.2 allowed 
Yellow AB FD&C Yellow 
NO.3 allowed 
Yellow OB FD&C Yellow 1?18 N ^ 
NO.4 allowed 
Guinea Green B F D & C Green f ^ f ^ ^ 
No.l allowed 
Ponceau SX FD&C Red i m Nm 
No.4 allowed 
Orange SS FD&C Orange f ^ N ^ 
No.2 allowed 
Oil Red XO FD&C Red f ^ ^ 
No.32 allowed 
Benzyl V i o l e t F D & C Violet ITO ^ 
4B No.l allowed 




Caramel is probably the most widely used food colorants in foods & drinks. 
It belongs to the group of melanoidin pigments (Rayner, 1991). This group of 
compounds is responsible for the attractive red-brown color of cooked foods. When 
carbohydrates are heated at high temperatures, they caramelize to produce a 
characteristic flavor and color. Melanoidin pigments are responsible for the color of 
caramels, malt extracts, and toasted carob flour (Rayner, 1991). The FDA defines 
caramel as “ the dark brown liquid or solid material resulting from the carefully 
controlled heat treatment of food-grade carbohydrates such as glucose, dextrose, 
lactose and sucrose" (Marmion, 1984). 
The European Economic Community (EEC) has assigned an E number, i.e 
El50, for caramel in 1962. In 1985, the International Technical Caramel 
Association (ITCA) classified it into 4 distinct classes according to manufacture and 
usage. In addition to its functions as food colorants, caramel has other valuable 
functional properties. It slowly absorbs oxygen and stabilizes colloidal systems, 
thus facilitating flavor retention as well as preventing hazes in products such as beers. 
Caramel also has emulsifying properties to facilitate the dispersion of 
water-insoluble materials, such as flavoring oils, in an aqueous phase (Chappel and 
Howell, 1992). 
1.2.1 Classes of caramel 
Caramel I 
Class I caramel, El50a, is also called plain caramel or caustic caramel. 
Making class I caramel is the simplest among the 4 classes, it is prepared by the 
controlled heat treatment of carbohydrates with alkali or acid (Licht et al, 1992). 
J 
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The ITCA committee allocated to this class an acceptable daily intake (ADI) ‘not 
specified' (Chappel and Howell, 1992). The major uses of this class include cookie 
fillings and pet food. 
Caramel II 
Class II caramel, El50b, is also called caustic sulphite caramel. Unlike 
class I, sulphite-containing compounds are added as catalysts in the heat treatment of 
carbohydrates (Licht et ai, 1992). No ADI was set (Chappel and Howell, 1992). 
Its usage is not common. 
Caramel III 
Class III caramel, El50c, is also called ammonia caramel (AC). Ammonia 
compounds are added in the heat treatment of carbohydrates (Licht et al, 1992). 
An ADI of 0-200 mg/kg body weight was allocated to this class (Chappel and 
Howell, 1992). It is used extensively as a color additive in beers, sauces, gravies 
and baking products (Houben et al., 1992). 
Caramel IV 
Due to the addition of ammonia-containing and sulphite-containing 
compounds (Licht et al., 1992)，class IV caramel (E150d) is also called 
ammonia-sulphite caramel. Similar to class III caramel, an ADI of 0-200 mg/kg 
body weight was established (Chappel and Howell, 1992). Its major uses are in soft 
drinks like Coca-Cola. 
4 
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1.2.2 Toxicological studies of caramel 
The 4 classes of caramel have been examined extensively by chemical 
analysis and safety testing. Class I, II and IV showed no toxicologically significant 
effects in mammals (Adams et al, 1992; Chappel and Howell, 1992; MacKenzie et 
a l , 1992). However, the safety of caramel III has been questioned in recent studies 
(Sinkeldam et al, 1988; Houben et al, 1992; MacKenzie et al, 1992). It has been 
shown that the presence of 2-acetyl-4(5)-tetrahydroxybutylimidazole (THI), an agent 
widely used as a component of ammonia caramel food coloring, leads to several 
drawbacks on the immune system of rats (Houben et al, 1992). 
Effects of class III caramel on the immune system of rats 
Administration of class III caramel has been associated with a reduction in 
total white blood cell and lymphocytes counts in rats (Sinkeldam et al., 1988; 
Houben et al., 1992). This effect is caused by the imidazole derivative 
2-acetyl-4(5)-tetrahydroxybLitylimidazole (THI), an agent widely used as a 
component of ammonia caramel food coloring (Sinkeldam et al., 1988; Houben et al, 
1992; MacKenzie et al, 1992). 
The reduction of total white blood cell counts occurred in spleen and popliteal 
lymph node, as well as in blood. Also, a stronger decrease in CD4+ (T-helper) cells 
than in CD8+ (T-cytotoxic) cells was observed (Houben et al., 1992). 
Hematoxylin and eosin staining of serial thymic sections of AC administered 
rats showed a decrease in cortical area and an enlargement of the medulla (Figure 1.1) 
(Houben et al., 1992). Moreover, an increased cell density was observed in the 
medulla. 
With the use of immunohistochemical staining techniques, the increase in 
medullary cell density was characterized as an increase in the number of mature 
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medullary thymocytes, mainly of the CD4+ phenotype. This observation, together 
with a decrease in the number of ER4+ cells, the recent thymus emigrants observed 
in spleen. This indicated a diminished migration of mature thymocytes from the 
thymus into the periphery. The changed lymphocyte migration patterns were 
suggested to play a role in the lymphopenia caused by THI (Houben et al, 1992). 
Further research indicated that most of these effects occurred only when the 
animals were fed with a diet low in vitamin B6. Addition of vitamin B6 to the diets 
of Caramel Color Ill-exposed rats can prevent the reduction in the number of blood 
lymphocytes (Noltes and Chappel, 1985; Conway and Paine, 1988; Sinkeldam et al, 
1988). 
A summary of the most important effects of caramel III and THI on the rat 
immune system is presented in Table 1.2. 
6 
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Table 1.2 Summary of the most important effects of caramel III and THI on 
the rat immune system. 
Parameter Observation  
Body and organ weights 
Body weight No effect 
Thymus weight No effect 
Spleen weight Decreased 
Cell counts 
White blood cell counts Decreased 
Blood lymphocyte counts Decreased 
Cell number bone marrow No effect 
Cell number thymus No obvious effect 
Cell number spleen Decreased 
Cell number lymph nodes Decreased 
Lymphocyte subsets 
Bone marrow No effect 
Blood, spleen, popliteal lymph nodes B/T ratios not affected, 
CD4+/CD8+ ratios decreased 
Histology 
Thymus Cortex/medulla area ratios 
decreased, increased cell density in 
medulla 
Spleen Lymphocyte depletion, increased 
numbers of megakaryocytes in red 
pulp 
Lymph nodes Lymphocyte depletion 
Immuno-histochemistry 
Thymus Increased numbers of mature 
medullary cells, reduced numbers 
of ED2+ macrophages in cortex 
Spleen Reduced number of ER4+ cells 
(recent thymus emigrants), reduced 
numbers of ED2+ macrophages in 
red pulp 
Immune functions 
T-cell dependent antibody responses Impaired 
Cell-mediated immune responses Impaired 
Natural Killer cell activity of spleen cells Decreased 
Natural Killer cell activity of peritoneal cells No effect 
Mitogen-induced proliferation of spleen cells Decreased 
Mitogen-induced proliferation of thymocytes Increased  
(Houben and Penninks, 1994) 
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Figure 1.1 Photomicrographs of thymus sections of rats. 
(A) a control rat; (B) a THI-exposed rat. (Houben et al.，1992). 
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1.3 Castanea mollissima 
Castanea mollissima, family Fagaceae, is commonly called Chinese chestnut. 
It reaches a height of 40 to 60 inches in a sunny exposure and a well drained soil. 
Leaves are simple, alternate, and deciduous with bristle-tipped and a hairy underside. 
They are 5 to 8 inches long. Flowers are present in June. Male flowers are small 
and white, 4 to 5 inches long. Female flowers are 1/2 to 3/4 inch long. Fruit a nut, 
which is edible and matures in September, 1 to 1 1/4 inches in diameter, brown, 





Free radicals and reactive oxygen species (ROS) 
Oxidants or reactive oxygen species (ROS) is a collective term that includes not 
only oxygen-derived radicals such as superoxide (O2") but also some non-radical 
derivatives of oxygen such as hydrogen peroxide (H2O2) (Halliwell et al., 1992). A 
free radical has one or more unpaired electrons and is unstable and more reactive 
than non-radical species. Some of the free radicals and other important oxidants 
found in living organisms are shown in Table 1.3 (Langseth, 1995). 
If free radicals are not inactivated, their chemical reactivity can damage all 
types of cellular macromolecules such as proteins, carbohydrates, lipids, and nucleic 
acids. Some of the types of damage that can result from the actions of free radicals 
are shown in Figure 1.2 (Langseth, 1995). The free-radical reaction has been 
associated with the pathology of several human diseases such as atherosclerosis and 
cancer (Anderson and Phillips, 1999). 
Lipid peroxidation 
Lipid peroxidation contributes to the development of cardiovascular diseases 
such as atherosclerosis (Brown and Goldstein, 1990). Also, the end products of this 
process can bring damage to protein and DNA. The oxidative modification of 
low-density lipoprotein (LDL) may be a key early step in atherogenesis. 
Macrophages, having the ability to oxidize LDL, take up the oxidized LDL rapidly 
and without regulation via scavenger receptors. Hence, it leads to the accumulation 
of cholesterol and the formation of foam cells (Fuller and Jialal, 1997). These foam 
cells contain large cytoplasmic deposits of cholesteryl ester and free cholesterol in 
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lipid droplets, are thought to be the earliest indicator of cardiovascular disease 
(Goldstein et al., 1979; Parthasarathy, 1994; Stone et al., 1996; Dragsted, 1998). 
The free-radical reaction of lipid peroxidation is important in the food industry 
and it may affect the food safety and appearance (Dragsted, 1998). 
Oxidative stress 
The human body has several mechanisms for defense against free radicals and 
reactive oxygen species. The various defences are complementary to one another 
because they act on different oxidants or in different cellular compartments. The 
examples of endogenous antioxidants are glutathione peroxidase (Langseth, 1995), 
superoxide dismutase (Halliwell, 1996) and catalase (Elstner et al., 1994). These 
enzymes can decrease the concentration of the most harmful oxidants. 
However, if exposure to exogenous sources of oxidants is high, the body's 
antioxidant defenses may be unable to cope. The imbalance between pro-oxidants 
and antioxidants is called oxidative stress (Gutteridge and Halliwell, 1994). 
Role of antioxidants 
An antioxidant is any substance that delays or inhibits, oxidative damage to a 
target molecule such as lipid, protein, nucleic acid and carbohydrate (Gutteridge and 
Halliwell, 1994). 
Exogenous antioxidants are available in fruits, vegetables and beverages. The 
synthetic antioxidants, such as butylated hydroxyanisole (BHA) and butylated 
hydroxytoluene (BHT), act as food additives can prevent peroxidation and improve 
the stability of lipids and lipid-containing foods (Onyeneho and Hettiarachy, 1991). 
Their chemical structures are shown in Figure 1.3. These antioxidants can 
terminate the free radical chains in the lipid oxidation by acting as electron donors. 
11 
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Natural antioxidants such as vitamin C (ascorbic acid) and carotenoids are 
found in fruits and vegetables. Ascorbic acid, acts as an oxygen scavenger, can 
react with oxygen and remove it in a closed system. A high consumption of food 
containing these antioxidants has been proved to be effective in preventing cancer 
and heart disease (Pryor, 1993; Steinmetz and Potter, 1996). 
Moreover, phenolic compounds are widely distributed in plants. One of the 
major groups of phenolic compounds is the flavonoids, which are important in 
contributing to the flavor and color of many fruits and vegetables and products 
derived from them such as wine, tea and chocolate. This is now much interest in 
the biological effects of phenolic compounds since evidence was found that diets rich 
in fruit and vegetables appear to protect against cardiovascular disease and some 
forms of cancer (Bors et al., 1990; Rice-Evans et al., 1996; Cook and Saman, 1996). 
Some dietary sources of flavonoids and phenolic acids are shown in Table 1.4 (Cook 
and Saman, 1996). 
Nowadays, there is an increasing demand on the antioxidants from natural 
products. They are regarded as more safe and more appreciated than the synthetic 
antioxidants. 
1.4.2 Methods used to evaluate the antioxidative activity 
Lipid peroxidation is one of the most important processes of the food 
deterioration because it may affect food safety, color, flavor and texture. 
Antioxidants may protect food quality by preventing oxidative deterioration of lipids 
(Kinsella et al.,1993). 
Several methods to determine free radical scavenging have been reported, the 
reaction with 1,1 -diphenyl-2-picrylhydrazyl (DPPH*) have received more attention. 
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1.4.2.1 DPPH* scavenging method 
DPPH* scavenging method is based on the measurement of free radical 
scavenging of the antioxidant compounds using a stable radical, DPPH* 
(Brand-Williams et al, 1995) and it was widely used in the determination of the free 
radical scavenging ability of the food sources. 
When DPPH* is mixed with methanol, it shows a strong absorption band at 515 
nm and appears in violet color. However, after the addition of antioxidant (AH), 
DPPH* is reduced and the absorbance decreases. Hence, in order to determine and 
compare the free radical scavenging ability of the antioxidants in food sources, the 
decreasing rate in the absorbance gives much information. 
DPPH. + AH • DPPH-H + A' 
1.4.2.2 High performance liquid chromatography (HPLC) 
High performance liquid chromatography (HPLC) is a powerful 
chromatographic technique. It can often easily achieve separations and analyses 
that would be difficult or impossible using other forms of chromatography. HPLC 
is the term used to describe liquid chromatography in which the liquid mobile phase 
is mechanically pumped through a column that contains the stationary phase. 
Reversed-phase (RP) chromatography is the most widely used chromatographic 
mode used in food items (Lea, 1988) and it is used to separate neutral molecules in 
solution on the basis of their hydrophobicity. RP-HPLC involves the use of a 
non-polar stationary phase and a polar mobile phase. 
There are two types of elution methods. Isocratic elution is used when the 
sample is introduced onto the column and eluted from it under the same set of mobile 
phase conditions. Gradient elution using two or more solvents, is most commonly 
performed with RP-HPLC. It involves a continuous change in the composition of 
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the mobile phase to achieve separation of sample components of widely varying 
affinities for the stationary phase. In the separation, the most polar component 
elutes first, followed by the non-polar component (Lindsay，1992). 
In this study, RP-HPLC was used in the separation of CP. Fractions were 
collected to assess the antioxidative activity using DPPH* scavenging method. 
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Table 1.3 Some important reactive oxygen species in living organisms. 
Free radicals 
Hydroxyl radical OH* 
Superoxide radical O2*' 
Nitric oxide radical NO* 
Lipid peroxyl radical LOO* 
Nonradicals 
Hydrogen peroxide H2O2 
Singlet oxygen 'O2 
Hypochlorous acid HOCl 





Proteins Increased turnover 
^ ^ Decreased enzyme activity •Ce l l iniurv 
Lipid peroxidation ^ Membrane damage / 
LDL damage 
� Atherosclerosis 
Secondary products / 
(aldehydes) / . 
DNA ^ Mutation/ 
Carbohydrate ^ Receptor alterations 
^ ^ ^ Reduced viscosity (synovial fluid) 











Figure 1.3 Chemical structures of synthetic antioxidants, BHA and BHT. 
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Table 1.4 Some dietary sources of flavonoids and phenolic acids. 
Flavonoid Source 
Catechins Tea, red wine 
Flavanones Citrus fruits 
Flavonols (e.g. Quercetin) Onions, olives, tea, wine, apples 
Anthocyanidins Cherries, strawberries, grapes 
Caffeic acid Grapes, wine, olives, coffee, apples, 
tomatoes, plums, cheiries 
(Cook and Saman, 1996) 
18 
Introduction 
1.5 Microtox® test 
Microtox® is the first commercial toxicity test using a living luminescent 
marine bacterium, Vibrio fischeri (formerly known as Photobactehiim phosphoreum, 
NRRL number B-11177) (Bulich, 1979). When properly grown, luminescent 
bacteria produce light as a by-product of their cellular respiration. Cell respiration 
is fundamental to cellular metabolism and all associated life processes. Bacterial 
bioluminescence is tied directly to cell respiration, and any inhibition of cellular 
activity (toxicity) results in a decreased rate of respiration and a corresponding 
decrease in the rate of luminescence (Tothill and Turner, 1996). The more toxic the 
sample, the greater the percent light loss from the test suspension of luminescent 
bacteria. Bacterial bioluminescence has proven to be a convenient measure of 
cellular metabolism and consequently, a reliable sensor for measuring the presence of 
toxic chemicals in aquatic samples. Strain B-11177 was originally chosen for the 
acute and chronic tests because it displayed a high sensitivity to a broad range of 
chemicals. 
1.6 Mutatox® test 
Mutatox® test is a biological test which uses a special dark mutant of 
luminescent bacterium {V fischeri, strain Ml69) to detect the presence of mutagenic 
or genotoxic agents. Unlike normal luminescent bacteria, strain Ml69 is a dark 
variant and produces very low light during its growth cycle. However, this strain 
exhibits increased light production when grown in the presence of sub-lethal 
concentrations of mutagenic agents (Azur Environmental, 1995). 
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1.7 Methods used to evaluate the functions of major organs 
1.7.1 Liver 
Liver, like pancreas, develops embryologically as a glandular outgrowth of the 
primitive gut. The major functions of the liver are, for examples, detoxification of 
metabolic waste products, destruction of spent red cells, synthesis and secretion of 
bile, synthesis of the plasma proteins and plasma lipoproteins and metabolic 
functions (Fox, 1999). Due to the many functions of the liver, no single test can be 
used alone and 'batteries' of tests are therefore applied in the assessment of patients 
with known or suspected liver disease. Liver function tests (e.g. bilirubin, 
aminotransferases, alkaline phosphatase, y-glutamyl transferase, etc.) are most 
common used for screening and monitoring the progress of patients with liver 
diseases (Corless and Middleton, 1983; Johnson, 1989). 
Alanine aminotransferase (ALT) 
ALT is an enzyme produced in hepatocytes, the major cell type in the liver. 
ALT is often inaccurately referred to as a liver function test, however, its level in the 
blood tells little about the function of the liver. The level of ALT in the blood is 
increased in conditions in which hepatocytes are damaged or die. As cells are 
damaged and ALT leaks out into the bloodstream. All types of hepatitis (viral, 
alcoholic, drug-induced, etc.) cause hepatocyte damage that can lead to elevations in 
the serum ALT activity (Walmsley and White, 1994). The ALT level is also 
increased in cases of liver cell death resulting from other causes, such as shock or 
drug toxicity. The level of ALT may correlate roughly with the degree of cell death 
or inflammation, however, this is not always the case. An accurate estimate of 
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inflammatory activity or the amount cell death can only be made by liver biopsy 
(Chopra and Griffin, 1985). 
Aspartate aminotransferase (AST) 
AST is an enzyme similar to ALT but less specific for liver disease as it is also 
produced in muscle and can be elevated in other conditions. AST is also 
inaccurately referred to as a liver function test by many physicians. In many cases 
of liver inflammation, the ALT and AST activities are elevated roughly in a 1:1 ratio. 
In some conditions, such as alcoholic hepatitis or shock liver, the elevation in the 
serum AST level may be higher than the elevation in the serum ALT level (Hubbard 
and Mechan, 1997). 
Alkaline phosphatase (ALP) 
Alkaline phosphatase is an enzyme, or more precisely a family of related 
enzymes, produced in the bile ducts, intestine, kidney, placenta and bone. An 
elevation in the level of serum alkaline phosphatase, especially in the setting of 
normal or only modestly elevated ALT and AST activities, suggests disease of the 
bile ducts. Serum alkaline phosphatase activity can be markedly elevated in bile 
duct obstruction or in bile duct diseases such as primary biliary cirrhosis. Alkaline 
phosphatase is also produced in bone and blood activity can also be increased in 
some bone disorders (Cella and Watson, 1989). 
/-glutamyl transpeptidase (GGTP) 
An enzyme produced in the bile ducts that, like alkaline phosphatase, may be 
elevated in the serum of patients with bile duct diseases. Elevations in serum 
GGTP, especially along with elevations in alkaline phosphatase, suggest bile duct 
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disease (Cella and Watson, 1989). Measurement of GGTP is an extremely sensitive 
test, however, and it may be elevated in virtually any liver disease and even 
sometimes in normal individuals. GGTP is also induced by many drugs, including 
alcohol, and its serum activity may be increased in heavy drinkers even in the 
absence of liver damage or inflammation (Fox, 1999). 
Bilirubin 
Bilirubin is the major breakdown product that results from the destruction of old 
red blood cells. It is removed from the blood by the liver, chemically modified by a 
process called conjugation, secreted into the bile, passed in the intestine and to some 
extent reabsorbed from the intestine (Hubbard and Mechan, 1997). Bilirubin 
concentrations are elevated in the blood either by increased production, decreased 
uptake by the liver, decreased conjugation, decreased secretion from the liver or 
blockage of the bile ducts. In cases of increased production, decreased liver uptake 
or decreased conjugation, the unconjugated or so-called indirect bilirubin will be 
primarily elevated. In cases of decreased secretion from the liver or bile duct 
obstruction, the conjugated or so-called direct bilirubin will be primarily elevated 
(Tennant, 1999). Many different liver diseases, as well as conditions other than 
liver diseases (e.g. increased production by enhanced red blood cell destruction), can 
cause the serum bilirubin concentration to be elevated. Most adult acquired liver 
diseases cause impairment in bilirubin secretion from liver cells that cause the direct 
bilirubin to be elevated in the blood. In chronic acquired liver diseases, the serum 
bilirubin concentration is usually normal until a significant amount of liver damage 
has occurred and cirrhosis is present. In acute liver disease, the bilirubin is 
increased relatively to the severity of the acute process. In bile duct obstruction, or 
diseases of the bile ducts such as primary biliary cirrhosis, the alkaline phosphatase 
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and GGTP activities are often elevated along with the direct bilirubin concentration 
(Marshall, 2000). 
1.7.2 Kidneys 
Kidney is a bean-shaped organ which removes nitrogenous wastes such as urea 
and excess substances such as mineral salts out of the body. Moreover, the kidneys 
maintain a constant osmotic potential of the body fluid by controlling the amount of 
water and mineral salts reabsorbed in the convoluted tubules and" the collecting duct. 
Great fluctuation in the water potential of the cells may kill them (Fox, 1999). 
Renal function tests are employed to evaluated the excretory, secretory and 
osmolar regulation dynamics of the kidneys. 
Urea nitrogen 
Urea is a nonprotein nitrogenous compound synthesized by liver from ammonia 
that is absorbed from the intestine or generated by endogenous protein catabolism. 
It is freely filtered through glomerulus and excreted in urine. However, some urea 
is passively reabsorbed with water in the proximal tubule. Blood urea analysis 
involves measurement of nitrogen, it is expressed as blood urea nitrogen. 
It reflects the balance between production and excretion of urea. Changes in 
protein intake, fluid balance, liver functions and renal excretion will affect the urea 
nitrogen level (Lum and Leal-Khouri, 1989). 
Creatinine 
Creatinine is the end product of creatine metabolism. It is an ideal substance 
for determining the renal clearance, because a fairly constant quantity is produced 
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within the body. 
With the measurements of serum creatinine and urine creatinine levels, 
creatinine clearance can be obtained (Walmsley and White, 1994). The term 
'clearance' refers to the relationship between the renal excretory mechanisms and the 
circulation blood levels of the materials to be excreted. Clearance refers the overall 
efficiency of glomerular functioning. 
Creatinine clearance is a sensitive indicator of glomerular function because 
those factors affecting the clearance are primarily due to alterations in renal function. 
These factors include the number of functioning nephrons, the efficiency with which 
they function, and the amount of blood entering the nephrons. Renal disease is the 
major cause of the reduction in the clearance value. Thus, this measurement is a 





Toxicology encompasses the study of the adverse effects of chemical and 
physical agents on living organisms and groups of organisms. It assesses the 
probability of hazards caused by such effects. Also, it estimates the results of these 
effects on individuals, populations, and ecosystems. Generally, toxicological 
studies deal with adverse effects ranging from acute to long-term (Schiefer et al, 
1997). 
1.8.1 Acute toxicity test 
The acute toxicity test is the first biological experiment done with the 
majority of compounds synthesized by the chemists or discovered in the environment 
(Zbinden, 1984). It often provides a wealth of information which can greatly 
influence the fate of a new chemical or a food substance. The results of acute 
toxicity tests are used as guidance for dose selection and design of further 
toxicological experiments. 
The acute toxicity of a chemical is its ability to cause either local damage (e.g. 
to skin or eyes) or systemic damage (affecting the body as a whole), as a result of 
one exposure to a relatively large amount of that substance (Schiefer et al, 1997). 
There are two types of parameters for the acute toxicity study: lethal and 
non-lethal. LD50 is a term commonly used to describe one type of acute toxicity. 
LD means "lethal dose，，，and the subscript 50 means that dose of toxicant which is 
acutely lethal to 50% of test organisms under controlled laboratory conditions. The 
smaller the LD50, the greater the toxicity. Conversely, the larger the LD50, the lower 
the toxicity. Mostly, the animals are closely observed for 14 days, and all adverse 
effects and deaths are recorded during this time. Besides, non-lethal parameters 
should also be taken into consideration in evaluating the acute toxicity if the animals 
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Still survive after the 14-day test period. Histopathological examination of the 
tissues would be a source of understanding the acute toxic effect of the substances 
for the investigation of the toxicants (Chan et al, 1992; Schiefer et al.�1997). 
1.8.2 Chronic toxicity test 
Chronic toxicity of a chemical or food substance is its ability to cause damage 
as a result of repeated exposure to relatively small amounts over a prolonged time 
period. The doses used in chronic toxicity tests are usually lower than those in the 
acute toxicity tests. This type of toxicity study at low dose exposure offers 
information on the cumulative effects of the toxicants (Chan et al, 1992). The 
chronic study examines adverse effects other than death. This may include adverse 




The objective of this research is to investigate the potential use of CP as a 
natural food colorant. The overall working hypothesis of this project is that CP is a 
safe natural pigment which can be applied on food items. Two major properties of 
a compound to serve such purpose include the stability of the compound and the 
safety of the compound for consumption. The thermal stability and light stability of 
CP will therefore be assessed. In addition to these properties, the antioxidative 
activity found associated with the CP preparation will also be studied as such activity 
may also attribute to CP's application in food items as a natural preservative (an 
antioxidant). For the safety evaluation of CP, both acute and chronic toxicity tests 
using experimental animals will be conducted. Genotoxicity of CP will be 
determined by the Mutatox test, a mutagenicity test based on the priniciple of the 
Ames test. 
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Chapter 2 Materials and Methods 
2.1 Plant Materials 
Castanea mollissima nuts were purchased from a local market in Yuen Long. 
The shells were peeled manually and kept at 4 � C prior to extraction. (Figure 2.1). 
2.2 Sample preparation 
For the extraction of CP, 1000 g Chinese chestnut shells were boiled in 6 L 
distilled water for five hours. The extract was filtered to remove the residue. It 
was then concentrated by a rotary-evaporator (Buchi, series R E l l l ) to a small 
volume. 
In the purification process, solvent extraction by dichloromethane and ethyl 
acetate were performed. The concentrated pigment solution (800 ml) and 
dichloromethane were mixed in 1:1 ratio in a 2 L separating funnel and extracted 
three times. The upper aqueous layer, containing the pigment, was again, extracted 
with ethyl acetate, in 1:1 ratio in a separating funnel and extracted three times. 
After phase separation, the lower brown aqueous layer was collected and lyophilized 
to a dry powder, which was about 30 g and stored in a desiccator. 
Over 5,000 g purified CP were prepared. The yield was about 1.5%. 
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. m 13 
Chinese Castanea chestnut shells 
Figure 2.1 The shells of Castanea mollissima, 
I 
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2.3 Pigment characterization 
2.3.1 Stability test 
In order to observe the stability of CP, the pigment was tested under different 
• temperature and light conditions. 
In high temperature treatment, a full spectrum (200 - 700 nm) of a 0.1 % CP 
solution was first measured with the spectrophotometer (Milton-Roy, Spectronic 
601). The 0.1 % CP solution was then treated under high temperature (121 °C) in 
an autoclave (Hirayama, HA-300P) for two 20-minute cycles. After autoclaving, 
the spectrum of CP was measured again. 
For another test, samples of 0.1 % CP were added to the 2 ml screw-cap tubes 
and subject to the following treatments: the tubes were placed at (1) room 
temperature (25 .�C) under light (day: 418.1 K lux; night: 11.9 K lux); (2) room 
temperature ( 2 5 � C ) in darkness (wrapped with aluminium foil); (3) low temperature 
(4 °C) in darkness (wrapped with aluminium foil). The experiment duration was 12 
months. 
The spectrum and absorbance at 400 nm of the samples from each treatment 
were determined once a month continuously throughout a year. 
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2.3.2 HPLC separation of CP 
Reversed phase-HPLC was used in the separation of CP. The analytical 
system included the Hewlett Packard (HP) series 1100 liquid chromatograph 
equipped with a HP 1100 photodiode array detector and a HP 1100 computer system. 
This system was connected with a guard column (Eclipse XDB-C18, 4.6 mm id x 
12.5 mm, 5 micron) and a separating column (Eclipse XDB-C18, 4.6 mm id x 150 
mm, 5 micron). 
A 1% CP solution was first filtered with a minipore filter (0.2 jiim) and then 
injected into the column. The injection volume was 100 ^il. The solvent system 
was (A) 100% ultra pure water and (B) 100% acetonitrile. A linear gradient of 0 to 
3 % solvent B was set within 35 minutes. The flow rate was 1 ml/min. The 
chromatogram was acquired at 400 nm. 
Fractions were collected at 1-minute intervals in order to identify the peak 
responsible for the CP. The collected fractions were dried with the use of a 
speed-vac (Savant, SPDl l lV) and then dissolved in methanol. 
2.3.3 Determination of antioxidative activity with the DPPH* scavenging 
method 
The DPPH* scavenging method was used to determine the free radical 
scavenging of CP (Brand-Williams et al, 1995). A 0.1% CP methanolic solution 
(500 jLil) was mixed quickly with a 6x10'^ M methanolic DPPH* solution (2 ml) in a 3 
ml cuvette. The methanolic DPPH* solution was freshly prepared. Absolute 
methanol was used as a control. 
In addition, the dried HPLC fractions were dissolved in methanol to make a 
concentration of 0.1% CP and was then tested in the DPPH* scavenging method. 
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Antioxidant standards including BHA (20 mM, 50 mM and 100 mM) and BHT (50 
mM and 100 mM) were used as references. A spectrophotometer with wavelength 
set at 515 nm (Milton-Roy, Spectronic 601) was used to read the samples 
continuously at half-minute intervals for 5 minutes. 
The reaction kinetic was plotted for the samples and standards. Each 
measurement was done in triplicates. The percentage discoloration on DPPH. at the 
first 5 minutes was calculated by the following formulae (Yen and Duh, 1994): 
A(0) - A � 
% Discoloration (t = 5)= x 100 
A(0) 
where A(0) is the absorbance of the mixture at time = 0 minute; 
A � is the absorbance of the mixture at time = 5 minutes. 
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2.4 Microtox® test 
In the present study, the test was carried out with an Azur Toxicity M500 
Analyzer (USA) following the test procedures outlined in the Microtox® Manual 
(Azur Environmental, 1995). All reagents and solutions were purchased from Azur 
Environmental. Zinc sulfate standard (ZnSC^JH�。）was used to check the 
performance of the complete test system (e.g. analyzer, reagent, diluent and 
reconstitution solution). In the Screening Test, a sample of CP was first diluted to 
different concentrations by adding diluent. A suitable concentration of CP was 
selected to do the Basic Test. It was done in triplicates and osmotic adjustment was 
performed. EC50s at 5, 15 and 30 minutes and 95% confidence intervals were 
calculated by the software MTX7 (Azur Environmental, USA). EC50 defines an 
effective concentration that can have a sub-lethal effect in 50% individuals in the test 
population. As all the CP samples showed distinct colors, the Color Correction 
Protocol was performed. 
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2.5 Mutatox® test 
Mutatox® test was carried out with an Azur Toxicity M500 Analyzer (USA) 
following the test procedures outlined in the Mutatox® Manual (Azur Environmental, 
1995). All reagents and solutions were purchased from Azur Environmental. 
Mutatox® test measures the light output at 16’ 20 and 24 hours of incubation at 27°C 
for the optimum growth temperature of a special dark mutant of luminescent bacteria 
(V.fischeh, strain Ml69). 
Toxicity from a test sample can interfere the Mutatox® test system. If the test 
sample concentration is highly toxic, the cells cannot express any mutagenic effects 
from the sample. Hence, all samples were measured at its EC50 for comparison 
and it was useful to select the test sample dilution which gave the greatest response 
ratio (highest light level at a sample dilution to the appropriate control light level). 
Suspected mutagenic agents are defined as those samples which induce the 
increase in light levels to at least two times the average control reading in at least two 
consecutive dilution cuvettes (Azur Environmental, 1995). The requirement for at 
least two positive dilutions avoids scoring a sample positive which may be a spurious 
result. 
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2.6 Acute Toxicity Test 
2.6.1 Animals 
Sprague-Dawley (SD) male rats of 200 - 230 g from the same colony were 
supplied from the Laboratory Animal Services Center, The Chinese University of 
Hong Kong. Mature rats, 8 weeks of age, were used in order to avoid the variability 
in white cell counts present in immature rats (Turton et al., 1989; Wolford et al, 
1987) (Figure 2.2). 
2.6.2 Housing and maintenance 
The animals were housed individually in suspended wire-bottom cages (Figure 
2.3). The wire mesh floors in this design of cage allow excrement to fall to 
absorbant papers underneath the cages. This minimized the need to disturb the cage 
occupants while changing papers. It had been reported that the heart rate, 
haemoglobin, plasma protein content, and serum glucose, pyruvate, and lactate 
concentrations in rats were elevated after cage movement to a table (Gartner et al, 
1980). 
The rats were maintained under the conditions of 22 - 25 °C with a 12-hour 
light-dark cycle and a relative humidity of 50 土 IQo/o. They were supplied with 
standard animal chow (PicoLab Rodent Diet 20，PMI Nutrition International, Inc.， 
USA) ad libitum. Test solutions were also provided ad libitum from clear plastic 
bottles fitted with stainless steel sipper tubes with ball valves. Acclimation period 
was seven days prior to assay. 
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Figure 2.2 A SD male rat of an acute treatment of CP. 
B j i i i i B r f f ^ ^ i i i i i M l 
I ^ E F V f f i f i n ^ m 
Figure 2.3 The experimental SD rats were housed in suspended wire-bottom 
cages. 
36 
Materials and Methods 
2.6.3 Experimental design 
The experimental period was 14 days. Male SD rats were randomly divided 
into two groups of eight rats. Group 1 was the control group, provided with 
distilled water and did not receive any treatment during the course of the experiment. 
Group 2 was the test group, provided with 8% CP solution in distilled water. 
During the experimental period, all rats were observed twice daily and 
moribund or dead animals noted. Body weights, food consumption and fluid intake, 
which was determined by weighing the water bottles, were recorded three times a 
week. 
At the termination of the experiment, blood samples and 24-hour urine samples 
were taken after an overnight fast. The rats were anesthetized by inhaling diethyl 
ether. Haematology, blood chemistry and urinalysis tests were done (Table 2.1). 
The blood was collected through the vena cava. A small part of blood, 1 ml was 
used in the test of haematology while the remaining blood, 5-8 ml was then left at 
room temperature for about 2 hours to allow complete clotting. After centrifugation 
at 3000 g for 15 minutes, serum, the clear supernatant was then pipetted into a clean 
micro-centrifuge tube and stored at 4°C and -70°C until further analysis in blood 
chemistry. At necropsy, weights of thymus, spleen, liver, kidneys, testes, heart, 
brain and caecal content were determined. 
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Table 2.1 Clinical pathology tests conducted in rat toxicity studies with CP. 
Haematology 
Haemoglobin* Haematocrit 
Mean corpuscular volume* Red blood cell counts 
Mean corpuscular haemoglobin* White blood cell counts, 
Mean corpuscular haemoglobin total and differential 
concentration* 
Blood chemistry 
Blood urea nitrogen Total protein 
Glucose Albumin 
Alanine aminotransferase Globulin 
Aspartate aminotransferase Albumin/globulin ratio 
Total Cholesterol Immunoglobulins, 
Triglycerides IgG, IgA and IgM 
High-density lipoprotein cholesterol y-Glutamyl transpeptidase 
Low-density lipoprotein cholesterol Calcium 
Total bilirubin Sodium 
Alkaline phosphatase Potassium 
Creatinine, Magnesium 
serum and urine Chloride 
Creatinine clearance 
Urinalysis 
Volume (24-hr) Bilirubin 
Physical appearance Blood 
pH Urobilinogen 
Protein Specific gravity 
Glucose Nitrite  
* Evaluated in the 9-month chronic toxicity test only. 
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2.6.4 Chemicals 
Dacie's formol-citrate 
Dacie's formol-citrate was a diluting fluid used in the determination of red-cell 
count. It was prepared by dissolving 3.0 g sodium nitrate and 1.0 ml 40% 
formaldehyde in 100 ml distilled water. This fluid was isotonic, it contained 
formaldehyde to fix the cells and prevent the growth the moulds, and citrate to 
prevent coagulation. 
White-cell count reagent 
The diluting fluid for white-cell counts completely lysed the red cells without 
damaging the white cells. It was 2% acetic acid with a little methyl violet added 
which stained the cells faintly. 
Phosphate buffered saline (PBS) 
PBS was used in the determinations of serum immunoglobulins. It was 
prepared by dissolving 156.01 g sodium dihydrogen phosphate, 141.96 g disodium 
hydrogen phosphate and 58.44 g sodium chloride in 1 L distilled water. 
Washing buffer fPBS-T) 
PBS-T was used in the determinations of serum immunoglobulins. It was 
prepared by dissolving 156.01 g sodium dihydrogen phosphate, 141.96 g disodium 
hydrogen phosphate, 58.44 g sodium chloride and 0.5 ml polyoxyethylene sorbitan 
monolaurate (Tween 20) (Sigma, PI379) in 1 L distilled water. 
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Acid buffer 
Acid buffer was used to determine serum chloride levels. The composition of 
which was as follows: polyvinyl alcohol (0.9% w/v), glacial acetic acid (10% w/v), 
nitric acid (0.64% w/v) and NaCl (0.004% w/v). 
10% buffered formalin 
Buffered formalin (10%) of pH 7.0 was used to fix organs in histological study. 
It was prepared by dissolving 8.5 g sodium chloride, 4.0 g hydrated sodium 
dihydrogen phosphate, 6.5 g disodium hydrogen phosphate in 100 ml formalin and 
900 ml distilled water. 
40 
Materials and Methods 
2.6.5 Clinical pathology test 
2.6.5.1 Haematology 
Determination of total red blood cells (RBC) 
After the blood was collected, immediately, 5 f^ l fresh blood was mixed well 
with 1 ml Dacie's formol -citrate giving a dilution of 1 in 200. About 8 diluted 
blood was then pipetted into a Neubauer counting chamber. After leaving the cells 
to settle for 2 minutes in a moist chamber, the cells were counted under the 200x 
microscope magnification (Figure 2.4). 
Determination of haematocrit or packed cell volume (PCV) 
A glass capillary tube was almost filled with non-clotted whole blood and was 
placed in a microhaematocrit centrifuge (Hettich, 201424). After centrifugation for 
3 minutes, the capillary tube (Figure 2.5) was removed and the value of haematocrit 
was determined by this formulae: Haematocrit (%) = b/(a+b) x 100%. 
Determination of total white blood cells 
Immediately after collected, 50 fresh blood was mixed well with 0.95 ml of 
white-cell count reagent giving a dilution of 1 in 20. About 8 \x\ diluted blood was 
then pipetted into a Neubauer counting chamber. After leaving the cells to settle for 
2 minutes in a moist chamber, the cells were counted using the 5Ox microscope 
magnification (Figure 2.4). 
Determination of differential white-cell count 
The examination of a stained blood film under the microscope could probably 
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produce more information than any other single test in haematology. It was 
therefore important to make and stain a film well, and to examine it systematically. 
The film was made according to Kirk et al. (1986). After drying the film for about 
two hours, the slide was stained by the differential count staining method (modified 
from Kirk et al, 1986). 
The procedure was as follows: The film was fixed in methanol for 10 minutes 
and then stained with May-Grunwald stain (Sigma, MG-500) diluted in an equal 
volume of buffered water for 10 minutes. Afterwards, the film was rinsed briefly 
with buffered water and stained with Giemsa stain (Sigma, GS-500) diluted in 1 in 
10 in buffered water for 30 minutes. Finally, it was rinsed with distilled water and 
dried in air. The film was then examined under a light microscope (lOOOx) and 
different types of white cells could be counted using a 5-unit counter (Danaher 
Controls, 0149000- 105). 
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Figure 2.4 Cell counting procedures for red-cell count squares 1，2, 3，4 and 5; 
for total white-cell count large squares A, B, C and D. 
Red-cell count: since there are 25 groups of squares in the central square millimeter, 
5 groups are equivalent to 0.2 m m � . If cell count in 5 groups of squares (i.e. 80 
small squares) = N. Then, the number of cells in 1 mm^ is N x 5. Since the depth 
is 0.1 mm, then the number of cells in 1 mm^ is N x 5 x 10. The blood is diluted 1 
in 200. Therefore, 
The number of red blood cells in 1 mm^ of whole blood 
= N x 5 X 10x200 
= N x 10,000 
where N = cell count in 5 groups (1-5) of squares (i.e. 80 small squares) 
Total white-cell count: 
If the number of cells counted in 4 mm^ is N，then the number of cells in 1 mm^ is 
N/4. Since the depth of the fluid is 0.1 mm and the dilution of blood is 1 in 20. 
Therefore, 
The number of white blood cells in 1 n W of whole blood 
= N / 4 x 1 0 x 2 0 
= N x 5 0 
where N = total number of cells in four of the larger corner squares (A-D) 
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Figure 2.5 A glass capillary tube used in determination of haematocrit. 
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2.6.5.2 Blood chemistry 
Determination of serum glucose and lipids 
Glucose 
Serum glucose levels were measured by a coupled glucose oxidase-peroxidase 
reaction (Sigma procedure 510). Color-enzyme substrate was prepared freshly by 
dissolving 1 capsule of glucose oxidase and peroxidase (PGO) enzyme mixture 
(Sigma, USA) in 100 ml distilled water and adding 1.6 ml of o-Dianisidine (Sigma, 
USA). One ml of color-enzyme substrate was mixed with 10 )il serum sample or 
glucose standard (0-100 mg/dL) and a brown color developed after 30 minutes 
incubation at 37�C water bath. Absorbance was taken at 450 nm. The procedure 
is based upon the following coupled enzymatic reactions: 
Glucose Oxidase 
Glucose + H2O + O2 ^ Gluconic acid + H2O2 
Peroxidase 
H2O2 + o-Dianisidine ^ Oxidized o-Dianisidine 
(colorless) (brown) 
Total cholesterol 
Serum total cholesterol was assayed using the commercial diagnostic kit (Sigma, 
352). Enzymatic reactions involved in the procedures are as follows: 
Cholesterol 
Estcrsss 
Cholesterol Esters + H2O ^ Cholesterol + Fatty Acids 
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Cholesterol 




^ Quinoneimine Dye + 4 H2 0 
The intensity of the color produced in quinonoimine dye which has an absorbance 
maximum at 500 nm is directly proportional to the total cholesterol concentration in 
the sample. 
Triglycerides 
Serum triglycerides was assayed using the commercial diagnostic kit (Sigma, 
336). Triglycerides are first hydrolyzed by lipoprotein lipase to glycerol and free 
fatty acids. The resulting formazan is highly colored and has an absorbance 
maximum at 500 nm. The intensity of the color produced is directly proportional to 
the triglycerides concentration of the sample. The enzymatic reactions involved in 
the assay are as follows: 
Lipoprotein 
Lipase 
Triglycerides ^ Glycerol + Fatty acids 
G K 
Glycerol + ATP ^ G-l-P + ADP 
G-l-PDH 
G-l-P + N A D ^ DAP + N A D H 
Diaphorase 
N A D H + INT ^ Formazan + N A D 
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High-density lipoprotein (HDL) cholesterol 
Total cholesterol in serum comprises all the cholesterol found in various 
lipoproteins. Cholesterol is the major component of the low density lipoproteins 
(LDL) fraction. It is also a minor component of the very low density lipoprotein 
(VLDL) and high density lipoprotein (HDL) fractions. In this assay, LDL and 
VLDL were first separated from HDL according to the Sigma procedure 352-4. 
The subsequent supernatant that contained HDL was then assayed for cholesterol 
(Sigma, 352). 
Low-density lipoprotein (LDL) cholesterol 
Serum low-density lipoprotein (LDL) cholesterol concentration was calculated 
by using the formula validated by Friedewald et al (1972): 
LDL cholesterol = Total cholesterol - HDL cholesterol — Triglycerides/5 
This equation was originally designed for humans, but was also applied in rats and 
hamsters (Balmer et al, 1996). 
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Determination of serum proteins 
Total protein 
Serum total protein was measured according to the Sigma procedure 541. It 
was measured based on the biuret method. The copper ions in alkaline biuret 
reagent, react with peptide bonds of serum proteins to form a purple color with an 
absorbance maximum at 540 nm. The intensity of the color is proprotional to the 
total protein concentration. 
Albumin 
Serum albumin levels were assayed using the commercial diagnostic kit (Sigma, 
625). It was based on the principle that serum albumin reacts specifically with 
bromcresol purple to form a stable blue-purple color complex with an absorption 
maximum at 600 nm. The intensity of the color is proportional to the serum 
albumin concentration in the sample. 
Globulin 
Serum globulin level was the concentration of albumin subtracted by that of 
total protein. 
Immunoglobulins (IgG, IgA and IgM) 
Determinations of total serum IgG, IgA and IgM were performed by 
enzyme-linked immunosorbent assay (ELISA) (Vos et ai, 1982). 
For IgA and IgM determinations, primary monoclonal mouse anti-rat IgA 
(Sigma, R0636) and IgM (Sigma, R0886) were used together with secondary 
anti-mouse IgG peroxidase conjugate (Sigma, A2304). 
For IgG determination, anti-rat IgG perxidase conjugate (Sigma, A5795) was 
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available, and no secondary antibody was needed. 
The substrate was 3,3',5,5'-tetramethyIbenzidine (TMB) (Sigma, T8665). In 
each study, a serum pool of the control animals was used as reference serum. 
The subsequent steps were shown in the folio wings: 
Antigen coating: 
Serum samples (100 |ul) were mixed with an equal volume of phosphate 
buffered saline (PBS) and were then added to each well of a 96-well plate (Sigma, 
MO 156). The plate was incubated at 37 °C for 30 minutes. After the incubation 
process, the coating solution was removed and the wells were washed three times 
with washing buffer (PBS-T). 
Primary antibody reaction: 
The monoclonal primary antibodies, anti-rat Ig-A (1 in 500 PBS-T), anti-rat 
IgM (1 in 1,000 PBS-T) and anti-rat IgG (1 in 50,000 PBS-T), 200 |LI1 each, were 
added to each well. After the incubation for two hours at room temperature, the 
solution was removed and the wells were washed three times with 200 )LI1 washing 
buffer. 
Application of secondary antibody (only for IgA and IgM determinations): 
The peroxidase conjugated secondary antibody, anti-mouse IgG was diluted 1 in 
50,000 PBS-T. The diluted antibodies (200 i^l) were then added to each well. 
After the incubation for two hours at room temperature, the solution was removed 
and the wells were washed three times with 200 jul washing buffer. 
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Substrate preparation and color development: 
For each microwell, 200 of T M B substrate solution was added and the plate 
was then incubated for 30 minutes at room temperature. After acidification with 
100 ^ LI of 0.5 M sulphuric acid stopping solution, a yellow color was produced and 
the absorbance was read at 450 nm. 
Albumin/Globulin (A/G) ratio 
Serum A/G ratio was calculated by the amount of serum globulin divided by the 
amount of serum albumin. 
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Determination of liver functions 
Alanine transferase (ALT) 
Serum ALT was reported to be stable for about 1 week when refrigerated and 
for about 2 days at room temperature (Henry, 1968). ALT loses activity when 
serum is frozen. Serum ALT levels were assayed by a diagnostic kit (Sigma, 505). 
Aspartate transferase (AST) 
Serum AST was reported to be stable for at least 2 weeks when refrigerated and 
possibly longer when stored frozen (Henry, 1968). Similar to ALT, serum AST 
levels were assayed by a diagnostic kit (Sigma, 505). The reactions for ALT and 
AST are as follows: 
. ALT 
Alanine + a-Ketoglutaric acid ^ Pyruvic acid + Glutamic acid 
AST 
Aspartic acid + a-Ketoglutaric acid • Oxalacetic acid 
+ Glutamic acid 
The oxalacetic or pyruvic acid formed in the above reactions reacts with 
2,4-dinitrophenylhydrazine. The color intensity of the resulting phenylhydrazones 
with a maximum absorbance at 505 nm is proportional to the transaminase activity. 
Alkaline phosphatase (ALP) 
Serum ALP levels were assayed using the commercial diagnostic kit (Sigma, 
104). The measurement is based upon the hydrolysis reaction: 
. ALP 
p-Nitrophenyl phosphate + H2O ^ p-Nitrophenol + Inorganic phosphate 
(colorless) (yellow) 
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When alkaline, p-nitrophenol is converted to a yellow complex readily measured at 
410 nm. The intensity of color formed is proportional to ALP activity. 
/-glutamyl transpeptidase (GGTP) 
Serum GGTP activities were measured using the commercial diagnostic kit 
(Sigma, 545). This assay is based on the transfer of the glutamyl group from 
L-glutamyl-p-nitroanilide to glycylglycine catalyzed by GGTP as follows: 
厂广丁 P 
L-glutamyl-p-nitroanilide ‘ p-Nitroaniline 
+ Glycylglycine + Glutamyl-glycylglycine 
, Acid 
p-Nitroaniline + Sodium nitrite ^ Diazo compound 
Diazo compound + Naphthylethylenediamine ^ Pink azo-dye 
The absorbance of the pink azo-dye measured at 540 nm is proportional to GGTP 
acitivity. 
Total bilirubin 
Serum total bilirubin levels were assayed using the commercial diagnostic kit 
(Sigma, 552). Both conjugated and unconjugated forms of bilirubin were measured. 
Determination of serum total bilirubin is generally based on its reaction with 
diazotized sulfanilic acid to form a colored product which is proportional to the 
bilirubin concentration and with an absorbance maximum at 540 nm. 
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Determination of renal functions 
Urea nitrogen 
Serum urea nitrogen levels were assayed using the commercial diagnostic kit 
(Sigma, 535). Urea concentration is directly proportional to intensity of the color 
(535 nm) produced in the following reaction: 
Diacetyl monoxime + Urea • Pink chromogen + Hydroxylamine 
Creatinine 
Both serum and urine creatinine levels were assayed using the commercial 
diagnostic kit (Sigma, 555). This assay is based on the following reaction: 
Alkali 
Creatinine + Picric acid • Colored complex 
The difference in color intensity measured at 500 nm before and after acidification is 
proportional to creatinine concentration. 
Creatinine clearance 
Creatinine clearance was calculated by: 
Creatinine clearance (ml/min.) 
=(Urine creatinine level x 24-hour urine volume) / Serum creatinine level 
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Determination of serum electrolytes 
Serum sodium, potassium, calcium and magnesium levels were determined, 
after approximate dilutions (20 serum in ultra-pure water), using a flame 
photometer (PHF 90D, ISA). Respective standard curves were constructed (Na+: 
0-150 mEq/L; Ca^ ": 0-20 mg/dL; K+: 0-10 mEq/L; Mg"": 0-10 mg/dL). 
Serum chloride levels were measured, via titration, using a chloride meter 
(Corning-eel, 920), conductivity being measured by an electrode after the addition of 
a 20 sample/standard directly into an acid buffer. 
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2.6.5.3 Urinalysis 
Urine volume 
A 24-hour urine sample was collected with the use of a metabolic cage (Figure 
2.6) one day before the end of the experiment. One rat was put inside the cage and 
the cage was placed on top of a funnel device so that urine falling on the sides of the 
funnel would go to the side arm and then came to the collecting jar, while the faeces 
pellets dropped into another collecting jar. 
Urinalysis dip-and-read test strips 
Urinalysis dip-and-read test strips (SELF-STIK, Korea) provide tests for, 
qualitatlively and semiquantitatively, urobilinogen (0-2 mg/dL), glucose (0-400 
mg/dL)�ketones (0-80 mg/dL), bilirubin (0-3 mg/dL), protein (0-1000 mg/dL), nitrite, 
pH (5-9), blood, specific gravity (1.000-1.030) and leukocytes. After dipping a test 
strip completely for no more than 1 second in fresh, well-mixed, and uncentrifuged 
urine specimen, the test results were compared with the color chart on the bottle label 
in good light within a proper reading time (30-60 seconds). 
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Figure 2.6 A metabolic cage used for the collection of urine sample. 
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2.6.6 Histological study 
Left lobe of the liver, kidney and thymus were all cut into small pieces and fixed 
individually in 10% buffered formalin for at least two days. The fixed tissues were 
then dehydrated in a series of ethanol and xylene, embedded in paraffin and cut into 
sections of 5 jam in thickness by using a microtome (Leica, 2035). The sections 
were then mounted on slide, stained by hematoxylin and eosin (H&E) and observed 
under light microscope after mounting with Canada Balsam. The detail procedures 
for dehydration, embedding and staining were presented in Table 2.2. 
2.6.7 Statistical analysis 
All results were expressed as arithmetical mean 土 standard deviation (SD). 
Statistical differences between groups were compared by one way Analysis of 
Variance (ANOVA) (by Excel) followed by Tukey test (by SPSS), with a significance 
level of 95% unless specified. 
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Table 2.2. Procedure for tissue preparation for light microscopic study. 
Procedure Reagent Time 
Fixing 10% buffered formalin At least 2 days 
Processing: Dehydration 50% EtOH 1.5 hours 
70% EtOH 1.5 hours 
85% EtOH 1.5 hours 
95% EtOH 2 hours 
Absolute EtOH 45 min 
Absolute EtOH 45 min 
Absolute EtOH 45 min 
Clearing Xylene:EtOH (1:1) 45 min 
Xylene 45 min 
Xylene •‘ 45 min 
Infiltration Paraffin wax 45 min 
Infiltration Paraffin wax 45 min 
Embedding: Tissues were embedded in paraffin wax 
Sectioning: Tissues were cut into sections of 5 [xm in thickness 
Staining: Dewax Xylene 5 min 
Xylene 5 min 
Hydration Absolute EtOH 1 min 
95% EtOH 1 min 
70% EtOH 1 min 
50% EtOH 1 min 
30% EtOH 1 min 
Running tap water 1 min 
Staining Mayer's hematoxylin 20 min 
Running tap water 1 min 
Acid EtOH 〜1-5 sec 
Running tap water 1 min 
Scott's tap water 2 min 
Running tap water 1 min 
0.5% aqueous Eosin 1-2 min 
Running tap water 1 min 
70% EtOH As short as possible 
95% EtOH As short as possible 
Absolute EtOH 2 min 
Absolute EtOH 2 min 
Xylene:EtOH(l:l) 2 min 
Xylene 2 min 
Xylene 2 min 
Mounting: Slides were mounted with Canada Balsam  
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2.7 Chronic Toxicity Test 
2.7.1 Animals 
Sprague-Dawley (SD) male weaning rats of 40 - 50 g from the same colony 
were supplied from the Laboratory Animal Services Center, The Chinese University 
of Hong Kong. 
2.7.2 Housing and maintenances 
The arrangements were the same as those described in Section 26.2 of 
Materials and Methods. 
2.7.3 Experimental design 
In this study, 6-month and 9-month chronic treatments were carried out 
independently. In each chronic treatment, male SD rats were randomly divided into 
groups of eight. Group 1 was the control group, provided with distilled water and 
did not receive any treatment during the course of experiment. Group 2 and group 
3 were the treatment groups, provided respectively with 0.25% and 1% CP solutions 
in distilled water. During the experimental period, all rats were observed twice 
daily and moribund or dead animals, if present, were noted. Body weights, food 
consumption and fluid intake were recorded weekly. 
In the 6-month chronic treatment, after carrying out the test for three months, a 
small volume (1.5 ml) of blood samples were obtained from the tail of each rat. 
The blood samples were analyzed by the tests of haematology and blood chemistry. 
At the end of the experiment, blood samples and 24-hour urine samples were 
taken after the overnight fast. The rats were anesthetized by inhaling diethyl ether. 
The blood was collected via the vena cava. Haematology, blood chemistry and 
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urinalysis tests were done (Table 2.1). At necropsy, macroscopic abnormalities 
were recorded; weights of thymus, spleen, liver, kidneys, testes, heart, brain and 
caecal content were taken. 
2.7.4 Chemicals 
The details were the same as those described in Section 2.6.4 of Materials and 
Methods with the addition of the following: 
Drabkin's solution 
Drabkin's solution was used to determine haemoglobin concentration. It was 
prepared by dissolving 200 mg potassium ferricyanide and 50 mg potassium cyanide 
in 1 L distilled water. The solution had a pH of 9.6 and was clear. 
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2.7.5 Clinical pathology test 
2.7.5.1 Haematology 
The details were the same as those described in Section 2.6.5.1 of Materials and 
Methods with the addition of the followings: 
Determination of haemoglobin (Hb) concentration 
Immediately after collection, 5 jiil fresh blood was mixed well with 1 ml 
Drabkin's solution and then left for 10 minutes. A spectrophotometer with 
wavelength set at 540 nm was used to read the samples against a standard (Sigma, 
525-18), using the Drabkin's solution as a blank. 
Determination of mean cell volume (MCV) 
M C V is the average volume in cubic micrometers of a single red cell. It is 
calculated by the following formulae: 
M C V (jW) = [PCV (%) X 10]/RBC (millions) 
Determination of mean cell haemoglobin (MCH) 
M C H is the average weight of haemoglobin in prcograms (pg) in a single red 
cell. It is calculated by the following formulae: 
M C H (pg) = [Hb (g/dL) x lOJ/RBC (millions/mm^) 
Determination of mean cell haemoglobin concentration (MCHC) 
M C H C is a good intdex of hypochromasia present. It is calculated by the 
following formulae: 
M C H C (%) = [Hb (g/dL) x 100]/PCV (%) 
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2.7.5.2 Blood chemistry 
The details were the same as those described in Section 2.6.5.2 of Materials and 
Methods. 
2.7.5.3 Urinalysis 
The details were the same as those described in Section j of Materials and 
Methods. 
2.7.6 Histological study 
Selected tissues including liver, kidney and thymus, also testis for the 9-month 
chronic test, were fixed in 10% buffered formalin for histopathological examination. 
The detail procedures for dehydration, embedding and staining were presented in 
Appendix B. 
2.7.7 Statistical analysis 
All results were expressed as arithmetical mean 土 standard deviation (SD). 
Statistical differences between groups were compared by one way Analysis of 
Variance (ANOVA) (by Excel) followed by Tukey test (by SPSS), with a significance 
level of 95% unless specified. 
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Chapter 3 Results 
3.1 Pigment characterization 
3.1.1 Stability test 
The spectrum of 0.1 % purified CP was shown in Figure 3.1a. Application of 
a high temperature by autoclaving did not change the color intensity of CP, and its 
spectrum remained unchanged. Effect of storage time on the absorbance of 0.1 % 
CP of the three treatments was shown in Figure 3.2. During the one year of storage, 
the absorbance reading at 400 nm was not significantly changed (p<0.05). 
3.1.2 HPLC separation of CP 
The aqueous extract of 1 % CP was separated into different fractions according 
to their polarities. The reversed phase HPLC profile of 1 % CP was shown in 
Figure 3.3. There was a major peak found at retention time of 19 min. The 
fraction collected from this peak was found to be light brown in color, indicating the 
presence of CP. The spectrum of CP of the HPLC-19 min. fraction was shown in 
Figure 3.1b. 
3.1.3 Antioxidative activities of CP preparations 
DPPH* scavenging method was used to determine and compare the free radical 
scavenging abilities of two CP preparations, namely the 0.1 % CP methanolic 
solution and the HPLC fraction collected as described in Section 3.1.2; and two 
synthetic antioxidants, B H A and BHT. 
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The reaction kinetic was plotted in Figure 3.4. The steeper the slope indicates 
the stronger the free radical scavenging ability of the sample. The descending order 
of free radical scavenging abilities of the samples and standards was as follows: 100 
m M B H A > 50 m M BHA > 25 m M BHA > 0.1 % CP > 100 m M BHT > 50 m M 
BHT > HPLC fraction. 
Moreover, the percentage discoloration of DPPH* at the first 5 minutes was 
shown in Figure 3.5. The percentage discoloration was the greatest for 0.1 % CP 
(95.79±8.15 %) and the lowerest for the HPLC fraction (26.71±1.25 %). 
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3.2 Microtox® test 
The toxicity of CP in Microtox® test was shown in Figure 3.6. The light level 
implies the survival of the bacteria in the tested sample. Therefore, the higher the 
light level means the lower the toxicity of the tested sample. Figure 3.6 showed that 
EC50 of the purified CP was much higher than that of the crude one, indicating the 
toxicity of CP was reduced as a result of purification to remove toxic impurities by 
organic solvents including dichloromethane and ethyl acetate. 
3.3 Mutatox® test 
Mutatox test was used to detect the presence of mutagenic agents in tested 
samples. The results on the mutagencity of CP were shown in Table 3.1. In this 
test, the mean media control light level reading was 2. If a sample had a light level 
at least two times the average control reading (i.e. 4) in at least two consecutive 
cuvettes, this sample was a suspected mutagen. As all of the cuvettes of CP had a 
light level reading below 4, so it was not considered as a mutagenic agent. 
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3.4 Acute toxicity test 
3.4.1 Growth rate 
The increases in body weights were shown in Figure 3.7. All rats were 
growing steadily. There was no significant difference (p<0.05) between the two 
groups and the final body weights were about 350 g. 
3.4.2 Food and fluid consumption 
For the food and fluid consumption, both groups had no significant difference 
(p<0.05). The food intake per rat was about 25 g a day while the fluid consumption 
per rat was 32 ml a day. Table 3.2 shows the consumption of drinking fluid and the 
corresponding CP intake of each group, which has no significant difference (p<0.05) 
between the 2 groups. The tolerated dose of CP per day in the treatment group was 
7143±109 mg/kg body weight, which is a very high dosage to the rats. 
3.4.3 Organ-weight 
Relative organ weights of thymus, kidneys, liver, heart, spleen, brain and testes 
were given in Figure 3.8. For the 8% CP-exposed rats, their relative testes weights 
(left testis: 0.46±0.03 % body weight; right testis: 0.47土0.03 % body weight) were 
significantly higher than the control (left testis: 0.42±0.04 % body weight; right testis: 
0.42±0.04 % body weight) only at p<0.05. There was no significant difference at 
pO.Ol. 
Relative caecal contents of control and 8% CP-exposed rats were shown in 
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Figure 3.9. They were obtained by the difference between the weights of full 
caecums and the empty caecums. Application of a high dosage, 8% CP to the 
treatment group, could significantly increase their caecal contents from 0.21 ±0.13 % 
body weight (control) to 0.72±0.41 % body weight (treatment) (p<0.05). 
67 
Results 
3.4.4. Clinical pathology tests 
3.4.4.1 Haematology 
Red blood cell count 
Both the control group (7.02±0.69 x lOVmm^) and the treated group (6.78±0.55 
X 1 OVmm^) had the red blood cell count within the reference range of 6.7-9.0 x 
lOVmm; (Gad and Chengelis，1992). There was no significant difference (p<0.05) 
in both groups (Figure 3.10a). 
Haematocrit 
The reference range of haematocrit is 39-55 % (Gad and Chengelis, 1992). All 
rats, with (52.89±1.59 %) or without treatment (52.50±2.85 %) had their 
haematocrits within the range with no significant difference (p<0.05) (Figure 3.10b). 
Total white blood cell count 
The reference range of total white blood cell count is 3.0-14.5 x lOVmm^ (Gad 
and Chengelis, 1992). Figure 3.10c showed that there was no significant difference 
(p<0.05) between the control and the treatment groups, and their total white-cell 
count were 9.75土4.70 x lOVmm^ and 8.70土3.45 x 10^/mm^ respectively. 
Differential white blood cell count 
The composition of five types of white blood cells, namely neutrophils, 
basophils, lymphocytes, monocytes and eosinophils were shown in Figure 3.11. 
Both the control and treatment groups had similar results. Lymphocytes (〜55o/o) 
and neutrophils (〜40o/o) occupied the majority of white blood cells, while monocytes 
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(〜5%) and eosinophils (〜5o/o) were in a little amount. Basophils were not 
detected. 
All data were within the reference range where the neutrophils is 11.5-41.6 %, 
basophils is 0 %, lymphocytes is 43.0-79.5 %, monocytes is 0-4 %, eosinophils is 
% (Gad and Chengelis , 1992). 
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3.4.4.2 Blood chemistry 
Glucose and lipids 
Glucose 
The reference range of fasting blood glucose concentration in rats is 92-192 
mg/dL (Minematsu et al., 1995). The rats in the treatment group had a comparative 
lower than normal blood glucose level at 82.06±18.05 mg/dL while the control group 
had a normal level at 105.05±29.66 mg/dL. Despite this, there was no significant 
difference (p<0.05) between the two groups (Figure 3.12). 
Total cholesterol 
The reference range of serum total cholesterol concentration in rats is 
53.5-112.9 mg/dL (Minematsu et al., 1995). Both the control and treatment groups 
had similar normal levels, which were 57.20±5.11 mg/dL and 56.99±8.84 mg/dL 
respectively (Figure 3.13a), with no significant difference (p<0.05). 
Triglycerides 
The reference range of serum triglycerides concentration is 31.3-115.7 mg/dL 
(Minematsu et al, 1995). Triglycerides concentration of rats in the treatment group 
was found to be 34.63±3.59 mg/dL while the control one was 40.23±5.76 mg/dL 
(Figure 3.13b), well within the reference range, with no significant difference 
(p<0.05). 
High-density lipoprotein (HDL) cholesterol 
Figure 3.13c showed the effect of 8% CP solution on the HDL cholesterol of SD 
rats. H D L cholesterol concentrations of the control and treatment groups were 
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found to be 30.86±4.39 mg/dL and 31.71±6.04 mg/dL respectively, with no 
significant difference (p<0.05). 
Low-density lipoprotein (LDL) cholesterol 
The rats drinking 8% CP solution had a LDL cholesterol level of 16.33±5.75 
mg/dL in serum while the control group had 20.88±9.55 mg/dL, with no significant 
difference (p<0.05) (Figure 3.13d). 
Proteins 
Total protein 
The reference range of serum total protein in rats is 4.85-5.73 g/dL (Minematsu 
et al, 1995). The rats in control and treatment groups had a total protein level of 
6.02±0.58 g/dL and 5.73±0.37 g/dL respectively (Figure 3.14a). There was no 
significant difference (p<0.05) between the two groups although the protein level of 
the control rats was slightly above the reference range. 
Albumin 
The rats in the control and treatment groups had an albumin concentration of 
1.08±0.20 g/dL and 1.01 ±0.12 g/dL respectively. No significant difference was 
found (p<0.05) (Figure 3.14b). 
Globulin 
The rats in the control and treatment groups had a globulin concentration of 
4.95±0.45 g/dL and 4.72土0.27 g/dL respectively. No significant difference was 
found (p<0.05) (Figure 3.14c). 
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Albumin/globulin (A/G) ratio 
The rats in the control and treatment groups had an A/G ratio of 0.22土0.04 and 
0.21 土0.02 respectively. No significant difference was found (p<0.05) (Figure 
3.14d). 
Immunoglobulins (IgG, IgA and IgM) 
Results of total serum IgG, IgA and IgM determinations were shown in Figures 
3.15. There was no significant difference (p<0.05) between the two groups for the 
three immunoglobulins measured. 
Liver function 
Aspartate transferase (AST) 
The serum AST level has decreased significantly (p<0.05) from 70.59± 10.94 
U/L (control) to 50.09±5.49 U/L (treatment) (Figure 3.16), which is also lower than 
the reference range of 55.6-94.1 U/L (Minematsu et al., 1995). 
Alanine transferase (ALT) 
The serum ALT level was not altered, being 11.17±1.78 U/L for the control 
group and 9.37±1.9 U/L for the treatment group (Figure 3.16). These levels, 
however, were lower than the reference range of 23.1-42.7 U/L (Minematsu et al, 
1995). 
Alkaline phosphatase (ALP) 
Application of 8% CP solution was having no significant effects (p<0.05) to the 
ALP levels of the rats. The rats in the control and treatment groups had 
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91.06±12.97 U/L and 97.92±14.95 U/L respectively (Figure 3.17a). These fell 
within the reference range of 56.8-128.0 U/L (Gad and Chengelis, 1992). 
r-glutamyl transpeptidase (GGTP) 
The treated rats drinking 8% CP solution exhibited a significant reduction 
(p<0.05) in serum GGTP level. GGTP levels of the control and treatment groups 
were 0.46±0.11 Units/mL and 0.24±0.09 Units/mL respectively (Figure 3.17b). 
Total bilirubin 
The reference range of serum total bilirubin level in rats is 0.093-0.189 mg/dL 
(Minematsu et al., 1995). Serum total bilirubin levels of the control and treatment 
groups were 0.14±0.04 mg/dL and 0.13±0.37 mg/dL respectively (Figure 3.17c). 
No significant difference (p<0.05) was found between the two groups. 
Renal function 
Urea nitrogen 
Blood urea nitrogen concentrations of the control (12.42±1.47 mg/dL) and 
treatment group (13.24±1.70 mg/dL) had no significant difference (p<0.05) and were 
within the reference range，11.9-18.8 mg/dL (Minematsu et al., 1995) (Figure 3.18). 
Creatinine 
Both serum creatinine and urine creatinine levels were measured (Figures 3.19). 
Serum creatinine levels of both control (0.72±0.09 mg/dL) and treatment groups 
(0.73±0.07 mg/dL), were high when compared with the reference range of 
0.267-0.351 mg/dL (Minematsu et al., 1995), although no significant difference 
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(p<0.05) was found. 
For the rats drinking the 8% CP solution, urine creatinine levels of control and 
treatment groups were 64.61 土21.97 mg/dL and 56.37±14.17 mg/dL, respectively, 
which had no significant difference (p<0.05). 
Creatinine clearance 
With the measurement of serum creatinine, urine creatinine levels and 24-hour 
urine volumes (Figure 3.19c), creatinine clearances of rats were determined. 
Creatinine clearances of the control and treatment groups, which had no significant 
difference (p<0.05), were determined to be 0.80士0.29 ml/min. and 0.76±0.15 ml/min. 
respectively (Figure 3.34). The clearances fell within the reference value of 
creatinine clearance in rats which is 1.2 ml/min. (Waynforth and Flecknell, 1992). 
Electrolytes 
Levels of serum sodium, chloride, potassium, calcium and magnesium ions 
were shown in Figures 3.20-3.21. No significant difference (p<0.05) was found. 
Sodium ion concentration of control and treatment groups were 130.73±14.82 
mEq/L and 131.16士9.81 mEq/L respectively (Figure 3.20a), a little lower than the 
reference range in rats which is 135.7-143.9 mEq/L (Minematsu et al., 1995). 
Chloride ion concentration of control and treatment groups were 101.79士1.51 
mEq/L and 101.03±6.82 mEq/L respectively (Figure 3.20b), well within the 
reference range in rats which is 95-106 mEq/L (Minematsu et al, 1995). 
Potassium ion concentration of control and treatment groups were 5.24土 1.09 
mEq/L and 5.12±0.82 mEq/L respectively (Figure 3.20c), well within the reference 
range in rats which is 4.61-5.57 mEq/L (Minematsu et al., 1995). 
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Calcium ion concentration of control and treatment groups were 10.85 ±2 64 
mg/dL and 10.17 土 1.22 mg/dL respectively (Figure 3.21a), the control value was a 
little higher than the reference range in rats which is 9.04 - 10.58 mg/dL (Minematsu 
et al, 1995). 
Magnesium ion concentration of control and treatment groups were 4.14士1.57 
mg/dL and 3.36土0.52 mg/dL respectively (Figure 3.21b), well within the reference 





There were no significant changes (p<0.05) in 24-hour total urine volume 
between the treatment and control groups. The urine volume of rats in the control 
and treatment groups were 13.84±5.79 ml and 14.25±5.52 ml respectively (Figure 
3.22). 
Urinalysis dip-and-read test strips 
The urine of the treatment group did not show any significant difference 
(p<0.05) from the control group in terms of color and the levels of urobilinogen, 
glucose, ketones, bilirubin, protein, nitrite, pH, blood, specific gravity and 
leukocytes. 
3.4.5 Histological study 
Photo-micrographs of liver, kidney and thymus sections of both of the control 
and treated rats were shown in Figures 3.23-3.25. Histological studies showed that 
the organs of the rats treated with 8% CP solution did not show any observable 
changes when compared to the control group. 
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3.5 Chronic toxicity test 
3.5.1 Growth rate 
Effect of 6-month and 9-month chronic toxicity treatments were given in 
Figures 3.26-3.27. All groups of rats were growing steadily. There was no 
significant difference (p<0.05) among the three groups and the final body weights 
were about 680 g. 
3.5.2 Food and fluid consumption 
For the food and fluid consumption, the three groups had no significant 
difference (p<0.05). The 6-month and 9-month chronic treatments had similar 
results. For the 6-month treatment, the daily uptake of CP in 0.25% CP-exposed 
rats was from the beginning of 750 down to 165 mg/kg body weight; while for the 
lo/o CP-exposed rats, the uptake was from the beginning of 3315 to 587 mg/kg body 
weight a day (Table 3.3). 
For the 9-month treatment, the daily uptake of CP in 0.25% CP-exposed rats 
was from the beginning of 781 down to 144 mg/kg body weight，while the total 
intake range of CP in 1% CP-exposed rats was from the beginning of 3125 down to 
607 mg/kg body weight a day (Table 3.3). 
3.5.3 Organ-weight 
Relative organ weights of thymus, kidneys and liver in the three groups of the 
6-month and 9-month chronic treatments were shown in Figure 3.28. Relative 
organ weights of heart, spleen, brain and testes were given in Figure 3.29. In 
addition, relative caecal contents were shown in Figure 3.30. All results had no 
significant difference (p<0.05). 
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3.5.4 Clinical pathology tests 
3.5.4.1 Haematology 
Red blood cell count 
The red blood cell count of the rats, ranged from 5.49 to 6.94 x l O V m ^ were a 
little lower than the reference range of 6.7-9.0 x l O V m ^ (Gad and Chengelis, 1992) 
(Figure 3.31a). No significant difference (p<0.05) was found among the groups. 
Haematocrit 
The haematocrit of the rats, ranged from 47.67 to 51.44 %, were within the 
reference range of 39-55 % (Gad and Chengelis, 1992) (Figure 3.31b). No 
significant difference (p<0.05) was found among the groups. 
Haemoglobin 
The haemoglobin of the rats was ranged from 18.49 to 19.67 g/dL (Figure 
3.32a). No significant difference (p<0.05) was found among the groups. 
Mean corpuscular volume (MCV) 
The M C V of the rats was ranged from 85.43 to 87.80 ^ m^ (Figure 3.32b). No 
significant difference (p<0.05) was found among the groups. 
Mean corpuscular haemoglobin (MCH) 
Like MCV, there were no significant treatment-related (p<0.05) changes 
observed in M C H among the three groups (Figure 3.32c). The value of M C H of the 
rats was between 31.69 to 35.48 pg. 
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Mean corpuscular haemoglobin concentration (MCHC) 
Effect of 9-month chronic treatment of CP on the M C H C of rats was shown in Figure 
3.32d. No significant difference (p<0.05) was found among the groups and the 
M C H C of the rats was ranged from 37.33 to 38.77 %. 
Total white blood cell count 
The reference range of total white blood cell count is 3.0-14.5 x 10^/mm^ (Gad 
and Chengelis，1992). In Figure 3.33, the total white-cell count of the rat was 
ranged from 8.48 to 12.10 x which fell within the reference range and with 
no significant difference (p<0.05). 
Differential white blood cell count 
The composition of five types of white blood cells, namely neutrophils, 
lymphocytes, monocytes, eosinophils and basophils of 6-month and 9-month chronic 
treatments were shown in Figure 3.34. All groups had similar results. 
Lymphocytes (ranged from 62.13 to 71.72 %) and neutrophils (ranged from 34.12 to 
40.53 %) occupied the majority of white blood cells, while monocytes (ranged from 
2.25 to 3.50 %) and eosinophils (ranged from 2.25 to 4.00 %) were in little amount. 
Basophils were not detected in all the groups. 
All of the above cell types fell within the following reference ranges. 
Neutrophils is 11.5-41.6 %, basophils is 0 %, lymphocytes is 43.0-79.5 %, 
monocytes is 0-4 % and eosinophils is 0-4 % (Gad and Chengelis, 1992). 
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3.5.4.2 Blood chemistry 
Glucose and lipids 
Effect of chronic treatment of CP on serum glucose (ranged from 92.12-135.74 
mg/dL), cholesterol (ranged from 72.06-108.04 mg/dL)�triglyceride (ranged from 
66.78-100.98 mg/dL), HDL cholesterol (ranged from 50.63-65.47 mg/dL) and LDL 
cholesterol (ranged from 12.46-22.31 mg/dL) levels were shown in Figures 
3.35-3.37. There were no significant treatment-related changes (p<0.05) among 
these parameters. 
Proteins 
Effect of chronic treatment of CP on serum total protein (ranged from 5.64-7.98 
g/dL), albumin (ranged from 0.78-1.32 g/dL), globulin (ranged from 4.83-5.48 g/dL), 
albumin/globulin ratio (0.16-0.26) and immunoglobulins (IgG: ranged from 
73.68-100 % of the controls; IgA: ranged from 79.55-100 % of the controls; IgM: 
ranged from 83.91-100 % of the controls) levels were given in Figures 3.38-3.39. 
No significant difference (p<0.05) was found among the groups except in the serum 
albumin/globulin ratio of the 6-month chronic treatment. The 1% treatment group 
(0.16±0.03) had a significantly (p<0.05) lower ratio than that of the control group 
(0.20土0.04). However, there was no significant difference at p<0.01. 
Liver function 
Serum aspartate transferase (AST) (ranged from 62.53-91.12 U/L), alanine 
transferase (ALT) (ranged from 18.77-29.86 U/L), alkaline phosphatase (ALP) 
(ranged from 50.91-69.94 U/L), y-glutamyl transpeptidase (GGTP) (ranged from 
0.44-0.87 Units/mL) and total bilirubin (ranged from 0.18-0.30 mg/dL) levels of the 
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control and treatment groups were shown in Figures 3.40-3.42. No significant 
difference (p<0.05) was found among the groups. 
Renal function 
Serum urea nitrogen (ranged from 11.78-13.49 mg/dL) and creatinine (ranged 
from 0.64-0.83 mg/dL) levels; urine creatinine level (ranged from 87.66-151.17 
mg/dL) and creatinine clearance (ranged from 0.78-0.83 ml/min) of the rats were 
given in Figures 3.43-3.44. There were no significant treatment-related changes 
(p<0.05) among the groups. 
Electrolytes 
Levels of serum sodium (ranged from 126.85-139.45 mEq/L), chloride (ranged 
from 96.88-107.50 mEq/L), potassium (ranged from 5.31-5.86 mEq/L), calcium 
(ranged from 7.71-9.24 mg/dL) and magnesium (ranged from 2.19-2.66 mg/dL) ions 





The 24-hour total urine volume of the rats was ranged from 8.25-14.00 ml 
(Figure 3.47). No significant difference (p<0.05) was found in the 9-month chronic 
treatment. However, in the 6-month treatment, the urine volume in the 0.25% 
treatment group (14.00±4.20 ml) was significantly greater than that of the control 
(8.25士3.47 ml) and the 1% treatment (10.31±2.24 ml) groups. 
Urinalysis dip-and-read test strips 
The urine of rats in the treatment groups in both 6-month and 9-month chronic 
treatments did not show any significant difference (p<0.05) from the control group in 
terms of color and the levels of urobilinogen, glucose, ketones, bilirubin, protein, 
nitrite, pH, blood, specific gravity and leukocytes. 
3.5.5 Histological study 
Photo-Micrographs of liver, kidney, thymus and testis sections of the control 
(0%) and treatment groups (0.25% and 1%) of the 9-month chronic treatment were 
shown in Figures 3.48-3.51. Histological studies showed that the organs of the rats 
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Figure 3.1 Spectrums of CP. (a) Purified CP after the purification process of 
solvent extraction, (b) further purification of CP by reversed-phase HPLC, at 
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Figure 3.2 Effects of temperature and light on the stability of CP. Treatment 1: 
O.io/o CP stored at room temperature ( 2 5 � C ) under light; Treatment 2: 0.1% CP 
stored at room temperature (25 °C) in darkness; Treatment 3: 0.1% CP stored at a 4 
under light. Results were means 土 SD of triplicate measurements. All results 
had no significant difference (p<0.05). 
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Figure 3.4 Hydrogen donating abilities of 0.1% CP, HPLC fraction and 
standards. The kinetics of samples and standards with DPPH* were plotted. 
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Table 3.1 Mutagenicity of CP in Mutatox® test. 
Reading of the Highest Light Levei* 
Media control 2 ± 1 
(mean) 
Purified CP' 2 ± 1 (< 4) 
The concentration of CP used in the test was 0.65 mg/ml which was the EC 50 in 
Microtox® test. 
S^uspected mutagenic agents are defined as those samples which induce or increase 
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Figure 3.7 Effect of acute treatment of CP on the body weight of rats. 
Concentration of purified CP exposed to rats were 0% and 8%. Results were means 




Table 3.2 Consumption of drinking fluid and CP of each group in acute 
toxicity test. 
Acute Toxicity Test 
Average Total intake of 
Group number % CP in Number of rats consumption of CP per day 
drinking fluid drinking fluid (mg/kg body 
per day (ml/day) weight) 
1 0% 8 30.62 ±4.09 0 
2 8 32.08 ±2.97 7143 ± 109 
Results were means 士 SD，no. of rats per treatment = 8. All results had no 
significant difference (p<0.05). 
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Figure 3.8 Effect of acute treatment of CP on the relative organ weights of rats. 
(a) organs of thymus, kidneys and liver; (b) organs of heart, spleen, brain and testes. 
Concentration of purified CP exposed to rats were 0% and 8%. Results were means 
土 SD，no. of rats per treatment = 8. R^esults having no significant difference at 
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Figure 3.9 Effect of acute treatment of CP on the relative weight of caecal 
contents of rats. Concentration of purified CP exposed to rats were 0% and 8%. 
Results were means 士 SD，no. of rats per treatment = 8. * Significantly difference 
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Figure 3.10 Effect of acute treatment of CP on blood chemistry of rats, (a) 
red blood cell counts; (b) haematocrit; (c) total white blood cell counts. Results 
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Figure 3.11 Effect of acute treatment of CP on the differential white blood cell 
counts of rats. Concentration of purified CP exposed to rats were 0% and 8%. 
Results were means 土 SD，no. of rats per treatment = 8. All results had no 
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Figure 3.12 Effect of acute treatment of CP on serum glucose levels of rats. 
Results were means 士 SD, no. of rats per treatment = 8. All results had no 
significant difference (p<0.05). 
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Figure 3.13 Effect of acute treatment of CP on serum lipids of rats, (a) 
cholesterol; (b) triglyceride; (c) H D L cholesterol; (d) LDL cholesterol. Results 
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Figure 3.14 Effect of acute treatment of CP on serum proteins of rats, (a) 
total protein; (b) albumin; (c) globulin; (d) albumin/globulin ratio. Results were 
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Figure 3.15 Effect of acute treatment of CP on serum immunoglobulins of 
rats, (a) IgG; (b) IgA; (c) IgM. Results were means 土 SD, no. of rats per 
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Figure 3.16 Effect of acute treatment of CP on serum AST and ALT levels of 
rats. Concentration of purified CP exposed to rats were 0% and 8%. Results were 
means 土 SD，no. of rats per treatment = 8. * Significantly difference when 
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Figure 3.17 Effect of acute treatment of CP on serum liver enzymes and 
bilirubin of rats, (a) alkaline phosphatase; (b) y-glutamyl transpeptidase; (c) total 
bilirubin. Results were means 土 SD, no. of rats per treatment = 8. * Significantly 
difference comparing with the control at p<0.05. All the other results had no 
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Figure 3.18 Effect of acute treatment of CP on serum urea nitrogen levels of 
rats. Results were means 土 SD，no. of rats per treatment = 8. All results had no 
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Figure 3.19 Effect of acute treatment of CP on creatinine of rats, (a) serum 
creatinine; (b) urine creatinine; (c) creatinine clearance. Results were means 土 SD, 
no. of rats per treatment = 8. All results had no significant difference (p<0.05). 
103 
Results 
( a ) 
150 1 
一 T T 
I ^ 100 -
+ -J 
i 旦 50-0) (f) 
oJ . , 
0 8 
Concentration of purified Castanea pigment 




•I : 100 - ——=—— ——r—— 
U LU 
E E ^^  
3 一 50 -
L. o 
CO 
oJ , , 
0 8 
Concentration of purified Castanea pigment 
exposed to rats (%) 
(c) 
6 - T 
> 
+ 兰 4 -
^ s 
E E 
S ^ 2 -
0) 乙 
CO 
0 J , , 
0 8 
Concent ra t ion of pur i f ied Castanea p i gmen t 
exposed to rats (%) 
Figure 3.20 Effect of acute treatment of CP on serum monovalent ions of rats. 
(a) sodium ion; (b) chloride ion; (c) potassium ion. Results were means 土 SD，no. 
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Figure 3.21 Effect of acute treatment of CP on serum divalent ions of rats, (a) 
calcium ion; (b) magnesium ion. Results were means 土 SD, no. of rats per 
treatment = 8. All results had no significant difference (p<0.05). 
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Figure 3.22 Effect of acute treatment of CP on 24-hr urine volumes of rats. 
Results were means 土 SD，no. of rats per treatment = 8. All results had no 





Figure 3.23 Photomicrographs of liver sections from rats of the acute toxicity 





Figure 3.24 Photomicrographs of kidney sections from rats of the acute 






Figure 3.25 Photomicrographs of thymic sections from rats of the acute 
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Figure 3.26 Effect of 6-month chronic treatment of CP on the body weight of 
rats. Concentration of purified CP exposed to rats were 0%, 0.25% and 1%. 
Results were means 土 SD，no. of rats per treatment = 8. All results had no 
significant difference (p<0.05). 
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Figure 3.27 Effect of 9-month chronic treatment of CP on the body weight of 
rats. Concentration of purified CP exposed to rats were 0%, 0.25% and 1%. 
Results were means 土 SD，no. of rats per treatment = 8. All results had no 
significant difference (p<0.05). 
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Table 3.3 Consumption of drinking fluid and CP of each group in 6-month and 
9-month chronic toxicity tests. 
6-Month Chronic Toxicity Test  
Average Total intake of 
Group number % CP in Number of rats consumption of CP per day 
drinking fluid drinking fluid (mg/kg body 
per day (ml/day) weight) 
1 0% 8 26.17 ±1.50- 0 
40.50 ±3.67 
2 0.25% 8 24.84 ±3.14- 165 ±23-
37.34 ± 6.15 750 ±43 
3 lo/o 8 25.07 ± 2.89- 587 ±56-
38.17±5.71 3315± 133 
9-Month Chronic Toxicity Test 
Average Total intake 
Group number % CP in Number of rats consumption range of CP per 
drinking fluid range of day (mg/kg 
drinking fluid body weight) 
per day (ml/day) 
1 0% 8 26.17 ±1.50- 0 
40.50 ±3.67 
2 0.25% 8 24.84 ±3.14— 144±11 — 
37.34 ±6.15 781 ±53 
3 1% 8 25.07 ±2.89— 607 ± 85 — 
38.17±5.71 3125±137 
Results were means 土 SD，no. of rats per treatment = 8. All results had no 
significant difference (p<0.05). 
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Figure 3.28 Effect of chronic treatments of CP on the relative organ weights 
(thymus, kidneys and liver) of rats, (a) 6-month chronic treatment; (b) 9-month 
chronic treatment. Concentration of purified CP exposed to rats were 0%, 0.25% 
and 1%. Results were means 士 SD，no. of rats per treatment = 8. All results had 
no significant difference (p<0.05). 
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Figure 3.29 Effect of chronic treatments of CP on the relative organ weights 
(heart，spleen, brain and testes) of rats, (a) 6-month chronic treatment; (b) 
9-month chronic treatment. Concentration of purified CP exposed to rats were 0%, 
O.250/0 and 1%. Results were means 土 SD，no. of rats per treatment = 8. All 
results had no significant difference (p<0.05). 
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Figure 3.30 Effect of chronic treatments of CP on the relative weights of 
caecal contents of rats, (a) 6-month chronic treatment; (b) 9-month chronic 
treatment. Concentration of purified CP exposed to rats were 0%, 0.25% and 1%. 
Results were means 土 SD, no. of rats per treatment = 8. All results had no 
significant difference (p<0.05). 
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Figure 3.31 Effect of chronic treatments of CP on blood chemistry (1) of rats. 
(a) red blood cell counts; (b) haematocrit. Concentration of purified CP exposed to 
rats were 0%, 0.25% and 1%. Results were means 土 SD, no. of rats per treatment = 
8. All results had no significant difference (p<0.05). 
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Figure 3.32 Effect of 9-month chronic treatment of CP on blood chemistry (2) of 
rats, (a) haemoglobin; (b) MCV; (c) MCH; (d) M C H C . Results were means 土 SD, 
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Figure 3.33 Effect of chronic treatments of CP on the total white blood cell 
counts of rats. Concentration of purified CP exposed to rats were 0%, 0.25% and 1%. 
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Figure 3.34 Effect of chronic treatments of CP on the differential white blood cell 
counts of rats, (a) 6-month chronic treatment; (b) 9-month chronic treatment. 
Concentration of purified CP exposed to rats were 0%, 0.25% and 1%. Results were 
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Figure 3.35 Effect of chronic treatments of CP on serum glucose levels of rats. 
Concentration of purified CP exposed to rats were 0%, 0.25% and 1%. Results were 
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Figure 3.36 Effect of chronic treatments of CP on serum lipids of rats, (a) total 
cholesterol; (b) triglyceride. Concentration of purified CP exposed to rats were 0%, 
0.25% and 1%. Results were means 土 SD, no. of rats per treatment = 8. All results 
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Figure 3.37 Effect of 6-month and 9-month chronic treatments of CP on serum 
lipids, (a) H D L cholesterol; (b) LDL cholesterol. Concentration of purified CP 
exposed to rats were 0%, 0.25% and 1%. Results were means 土 SD，no. of rats per 
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Figure 3.38 Effect of chronic treatments of CP on serum proteins of rats, (a) total 
protein; (b) albumin; (c) globulin; (d) albumin/globulin ratio. Concentration of purified 
CP exposed to rats were 0%, 0.25% and 1%. Results were means 士 SD，no. of rats per 
treatment = 8. * Results having no significant difference at p<0.01. All the other results 
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Figure 3.39 Effect of chronic treatments of CP on serum immunoglobulins of 
rats, (a) IgG; (b) IgA; (c) IgM. Concentration of purified CP exposed to rats 
were 0%, 0.25% and 1%. Results were means � SD’ no. of rats per treatment = 8 
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Figure 3.40 Effect of chronic treatments of CP on serum aminotransferase of 
rats, (a) AST; (b) ALT. Concentration of purified CP exposed to rats were 0%, 
0.25% and 1%. Results were means 土 SD, no. of rats per treatment = 8. All 
results had no significant difference (p<0.05). 
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Figure 3.41 Effect of chronic treatments of CP on serum liver enzymes of rats. 
(a) alkaline phosphatase; (b) y-glutamyl transpeptidase. Concentration of purified 
CP exposed to rats were 0%, 0.25% and 1%. Results were means 土 SD，no. of rats 
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Figure 3.42 Effect of chronic treatments of CP on serum total bilirubin levels 
of rats. Concentration of purified CP exposed to rats were 0% �0.25% and 1%. 
Results were means 土 SD, no. of rats per treatment = 8. All results had no 
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Figure 3.43 Effect of 6-month and 9-month treatments of CP on serum urea 
nitrogen levels of rats. Concentration of purified CP exposed to rats were 0%, 
O.250/0 and 1%. Results were means ± SD, no. of rats per treatment = 8. All 
results had no significant difference (p<0.05). 
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Figure 3.44 Effect of chronic treatments of CP on creatinine of rats, (a) 
serum creatinine; (b) urine creatinine; (c) creatinine clearance. Concentration of 
purified CP exposed to rats were 0%, 0.25% and 1%. Results were means 土 SD, no. 
of rats per treatment = 8. All results had no significant difference (p<0.05). 
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Figure 3.45 Effect of chronic treatments of CP on monovalent ions of rats, (a) 
sodium ion; (b) chloride ion; (c) potassium ion. Concentration of purified CP 
exposed to rats were 0%, 0.25% and 1%. Results were means 士 SD，no. of rats per 
treatment = 8. All results had no significant difference (p<0.05). 
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Figure 3.46 Effect of chronic treatments of CP on divalent ions of rats, (a) 
calcium ion; (b) magnesium ion. Concentration of purified CP exposed to rats were 
0%, 0.25% and 1%. Results were means 土 SD，no. of rats per treatment = 8. All 
results had no significant difference (p<0.05). 
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Figure 3.47 Effect of chronic treatments of CP on 24-hr urine volumes of rats. 
Concentration of purified CP exposed to rats were 0%, 0.25% and 1%. Results 
were means 土 SD，no. of rats per treatment = 8. Significantly difference comparing 





Figure 3.48 Photomicrographs of liver sections from rats of the 9-month 





Figure 3.49 Photomicrographs of kidney sections from rats of the 9-month 








Figure 3.51 Photomicrographs of seminiferous tubule of testis sections from 




Chapter 4 Discussion 
4.1 Pigment characterization 
Stability is a very important factor for a pigment to be a potential natural 
colorant. The natural pigments associated with most fresh food, especially fruits 
and vegetables, are vivid and brilliant. However, these pigments are subject to 
adverse physical and chemical conditions during processing that cause their partial 
degradation. Processing therefore often results in undesirable changes in color and 
thus diminishes the visual perception of foods. Food manufacturers and processors 
thus require to replace the lost color if the acceptable attractive appearance is to be 
restored (Ghorpade et al, 1994). 
Synthetic color additives such as Allura Red and Sunset Yellow are widely used 
due to their coloring properties, uniformity, stability and low cost, although health 
problems occur after prolonged use (Goyle and Gupta, 1998). 
A variety of beers, biscuits, gravy powders, confectionery products and baked 
foods were made with the addition of class III caramel, evidence showed that a 
marker component of the caramel was only partially stable during the manufacture, 
packaging and storage of the foods (Coffey et al., 1997). 
In this study, CP was found to be very stable. High temperature at 121 °C 
(autoclaving temperature) did not alter the spectrum of CP solution (Figure 3.1a). 
Moreover, there was no significant effect (p<0.05) on the absorbance of CP under 
various conditions for a period of 12 months (Figure 3.2). Furthermore, pH profile 
of CP was found to be stable (Wong, unpublished data). 
As the consumers' concern on the safety of synthetic colorants remains and the 
demand for natural pigments as food colorants has increased, a natural and stable CP 
is therefore suitable to be used in the food industry to enhance the aesthetic appeal of 
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processed food. For instance, as CP was found to be heat and light stable, these two 
properties allow CP to be a food colorant which can be applied on canned food, 
baking products and gravy powders. 
In the purification of CP, the solvents dichloromethane and ethyl acetate were 
used to remove the impurities in the crude pigment. HPLC has been commonly 
used to isolate and identify pigments such as carotenoids (Deli et al, 1996), 
anthocyanins (Yoshida et al., 1996; Rodriguez et al., 1998) and synthetic colorants 
(Virtanen et al, 1999). Further purification of CP by reversed-phase HPLC was 
carried out. From the HPLC profile shown in Figure 3.3," a major peak at retention 
time of 19 minute was detected. The collected fraction was light brown in color. 
This indicated that one major pigment attributes to the pigmentation of chestnut 
shells. The spectrum of HPLC-19 minute fraction of CP (Figure 3.1b) was different 
from that of purified CP (Figure 3.1a). The former showed much less absorption in 
‘ the U V light region (200-400 nm) than the latter. This further suggested that 
HPLC-19 min. fraction of CP contained less impurities and therefore was much more 
pure than the purified CP which was solely purified by the process of solvent 
extraction using dichloromethane and ethyl acetate. 
B H A and BHT are free radical scavengers and have been shown to possess 
strong antioxidative activities in many studies (Camire and Dougherty, 1998; Iverson, 
1999). However, their potent tumor-promoting effects (Lindenschmidt et al, 1986) 
have aroused public rejection. On the contrary, vitamin C (ascorbic acid), vitamin 
E (a-tocophero) (Tsao, 1997) and phenolic compounds such as catechin, quercetin 
and caffeic acid (Chen and Ho, 1997) have been intensively used for food additives 
nowadays due to their high antioxidative activities and their natural in origin. 
Antioxidants can be classified into three categories based on their reaction 
mechanisms: (1) preventing radical formation either by chelation of transition metal 
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ions or by inhibition of enzymes that generate free radicals (Kono et cd., 1998); (2) 
scavenging free radicals once they formed (Salah et al, 1995); and (3) acting as 
synergists with other antioxidants (Jia et al., 1998). The results obtained in the 
DPPH* scavenging assay indicated that CP exhibited strong antioxidative activity as 
they can scavenge the free radical (Figure 3.4). The antioxidative activity of a 0.1% 
CP solution was equivalent to that of 25 m M BHA. The CP purified by HPLC had 
a much lower antioxidative activity. Only about 25% of the antioxidative activity 
remained in the HPLC-purifed pigment. This suggests that both CP and other 
impurity compounds have such activity. -
For the applications of CP in the food industry, CP is not only a natural colorant 
but also can be used as a food preservative likes B H A and BHT. CP can be added 
to food products to extend the shelf life by preventing lipid peroxidation. 
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4.2 Toxicological studies of CP 
More and more synthetic food coloring additives, after prolonged use, have 
been found to have health problems such as indigestion, anaemia, pathological 
lesions in brain, kidney, spleen and liver, tumours and cancer, paralysis, mental 
retardation, abnormalities in offspring, growth retardation, and eye defects resulting 
in blindness. It is recommended that these hazardous additives should be avoided 
to use in food (Aboel et al, 1997; Goyle and Gupta, 1998). Natural colorants 
would be good candidates to replace the synthetic ones. 
In this project, toxicological studies of CP were conducted both on bacteria 
(Microtox® test and Mutatox® test) and rats (acute toxicity test and chronic toxicity 
test). 
Microtox® test has been used to assess the toxicity of over 1,300 chemicals 
(Kaiser and Palabrica, 1991). It is mainly used for testing environmental toxicity. 
In this study, Microtox® test was used as a preliminary test on the toxicity of CP. 
The procedures are simple, inexpensive and data can be obtained within a short 
period of time. In general, EC50 of a sample at 2.0 ppm (0.002 mg/ml) was 
considered to be highly toxic (Hong and Pehkonen, 1998). The EC50 values of 
purified CP and crude CP were found to be 650 ppm (0.65 mg/ml) and 360 ppm 
(0.36 mg/ml) respectively. These high EC values suggest that CP is relatively 
non-toxic and safe to be included in food items. In addition, purification using 
dichloromethane and ethyl acetate was able to remove toxic impurities that present in 
the crude pigment because the purified CP had a higher EC50 value than that of the 
crude one (Figure 3.6). 
Like Microtox® test, Mutatox® test was used as a screening or preliminary test 
on the mutagenicity of CP. The principle of Mutatox® test is based on the Ames 
test. Although it does not necessarily follow that because a compound is mutagenic 
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it is also carcinogenic, the correlation is quite high. Thus, the knowledge that a 
compound is mutagenic in a bacterial system serves as a warning of possible danger 
(Madigan et al., 1997). Mutatox® test has been used in the analyses of fatty acid 
derivatives (Sun et ai, 1998) and environmental samples of landfill leachates (Beg 
and Al, 1998). In this study, Mutatox results suggested that CP was not a 
mutagenic agent (Table 3.1). 
In the 14-day acute toxicity study, a high dosage of 8% CP in the drinking water 
was used to feed the rats. The daily uptake of CP of a treated rat was 7143 mg/kg 
body weight which was more than 35 times to the daily maximum uptake of caramel, 
200 mg/kg body weight (Chappel and Howell, 1992). 
No death or adverse effect was observed during this study. Physical 
parameters including body weights, food and fluid consumption were normal for 
control and treated rats. Comparably, there were also no treatment-related 
ante-mortem observations of the above parameters in the rats having a high 
consumption of class III caramel or ammonia caramel (AC) in a 4-week toxicity 
study (MacKenzie et al, 1992). 
For the relative organ-weight data, there was no significant difference (p<0.05) 
in all the organs except the testes. This difference was, however, insignificant at 
p<0.01 (Figure 3.8b), which might be only due to the generally large variations 
among the individuals. For the relative caecal contents of the two groups (Figure 
3.9), addition of 8% CP to the drinking water of the treatment group significantly 
increased (p<0.05) the relative caecal content. Located at the junction of the colon 
and the ileum, the caecum of the rat was the blind end of which forms the appendix. 
It contains symbiotic bacteria and protozoa which secrete cellulase to digest cellulose 
which is a tough fibrous carbohydrate found in plant cell walls (Rowett, 1974). The 
rats of the treatment group consumed enormous amounts of plant components, 
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containing in the 8% CP solution. These rats were trying to adapt during the 14-day 
period. Hence, it was possible that the increase in caecal content might be due to 
the large quantities of cellulose, the plant components and the symbiotic bacteria 
being induced by the CP. 
In the 6-month and 9-month chronic treatments, mean body weight gains, fluid 
consumption and relative organ-weight of rats were not affected by feeding CP under 
the conditions of this study. Unlike the 14-day acute test, there was no significant 
difference in the caecal contents among the groups (Figure 3.30). Therefore, the 
increase in caecal contents did not occur in the rats which have adapted to the 
ingestion of CP during the long period of treatment although they received a 
relatively low concentration of CP, i.e. 0.25 % and 1 %, in the chronic treatments. 
In the case of AC- and THI-exposed rats, it was found that there was a slight 
decrease in the absolute liver weight (to 89%; p<0.05) and absolute thymus weight 
(to 89%; p<0.01). Moreover, the relative kidney weights were increased by 8% 
(p<0.05) and the relative weights of spleen were significantly (p<0.05) decreased to 
71% (Houben et al, 1992). 
The haematology results of the acute and chronic toxicity studies in this project 
demonstrated that the effect of CP in the rats was negligible. The treatment rats had 
normal red-cell count, haematocrit, total white-cell count and differential white-cell 
count. Therefore, by the study of the composition of the blood and their production, 
the blood in rats of the treatment group was found functioning normally. 
In the case of caramel, there were a number of significant differences (p<0.05) 
in the treatment group with a high consumption of class III caramel. Total 
leukocyte numbers of AC- and THI-exposed rats were decreased to about 34% of the 
control counts, due to a significant reduction in the number of blood lymphocytes to 
about 26% (Houben et al., 1992). Total numbers of spleen cells in AC- and 
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THI-exposed rats were also decreased to 47% and 43% of the control counts 
respectively (Houben et al., 1992). Cell numbers isolated from popliteal lymph 
nodes were decreased to 38% and 39% in AC- and THI-exposed rats respectively 
(Houben et al., 1992). 
For the rats having a high dosage of CP, like caramel (MacKenzie et al., 1992), 
there was no significant difference in serum glucose, total cholesterol, triglycerides, 
H D L cholesterol and LDL cholesterol levels when compared to the control group. 
One point to note, the fasting blood glucose amount in the treatment group of the 
acute study was slightly lower than the given reference range (Figure 3.12). This 
leads to a further question that whether CP can reduce the glucose level in rats. 
Nevertheless, there was no elevation of glucose and lipids, hence indicating that a 
high dosage of CP did not have any harmful effects to the cardic system of the rats. 
The assessment of proteins can provide an overall picture of protein 
homeostasis, in particular, the immunoglobulins, which are important in the immune 
system. In the acute test, there was no significant difference (p<0.05) found in 
measurements of serum total protein, globulin, A/G ratio and immunoglobulins of 
the two groups. In the 6-month chronic treatment, 1% CP-exposed rats had a 
significantly lower (p<0.05) A/G ratio when compared to the control group, but 
insignificant at p<0.01 (Figure 3.38d). The A/G ratio indicates the balance between 
the total albumin and total globulin and is usually evaluated in relation to the total 
protein level (Cella and Watson, 1989). In this study, there was no significant 
difference (p<0.05) in the total protein levels of the experimental rats (Figure 3.38a). 
The intake of caramel, like CP, can induce no significant difference (p<0.05) for 
most of the factors tested above (MacKenzie et al” 1992). However, it was found 
that the total IgA levels in the ammonia caramel (AC)-exposed rats were decreased 
to 49% of control rats (Houben et al., 1992). 
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In the liver function test, like caramel (MacKenzie et al., 1992)，several 
enzymes including aspartate transferase (AST), alanine transferase (ALT), alkaline 
phosphatase (ALP) and y-glutamyl transpeptidase (GGTP), and total bilirubin in 
serum of the rats were examined. Changes in amount of these substances implies 
liver malfunction. 
AST and ALT are the two enzymes commonly assayed for evaluating liver cell 
damage. Normally, the increase in AST level is associated with the liver cell 
damage, hepatitis and/or myocardial infarction. With mild hepatocellular damage, 
ALT levels are higher than AST while the elevation of the latter was found in more 
severe cellular necrosis due to the release of mitochondrial enzymes (Walmsley and 
White, 1994). In the acute study，there was however，only a significant reduction 
(p<0.05), not elevation of AST level in the treatment group (Figure 3.16). The 
decrease in AST level may indicate the decreased hepatocellular production or 
release. However, it was not a pathologically important phenomenon (Hall, 1992). 
On the contrary, CP intake may, on the other hand, have a protective function to the 
hepatic systems of the rats. 
GGTP level in the 8% CP-exposed rats was significantly (p<0.05) lower than 
that of the control group (Figure 3.17b). Most GGTP in serum derives from 
hepatobiliary sources and elevated levels lead to hepatobiliary disease (Cella and 
Watson, 1989). Like AST, the reduced level of GGTP in the treated rats does not 
indicate any harmful effects. 
Serum total bilirubin and the other enzymes such as ALT and ALP which were 
also tested for A C (MacKenzie et al., 1992)，had no significant treatment-related 
changes (p<0.05). 
By measuring these factors in the liver function test, application of 8% CP in the 
treatment group did not cause any adverse effect to their hepatic systems. 
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In the renal function test, blood urea nitrogen, serum creatinine, urine creatinine 
and creatinine clearance levels were similar and normal in both of the control and 
treatment groups. Creatinine clearance is a sensitive indicator of glomerular 
function and renal disease is the major cause of reduced creatinine clearance (Cella 
and Watson, 1989). No significant difference (p<0.05) was detected for all the renal 
parameters. Thus, all rats had good functions of kidneys. 
Electrolytes are substances that dissociate into electrically charged ions when 
dissolved. Both cations (sodium, potassium, calcium and magnesium) and anions 
(chloride) affect the electrical and osmotic functioning of the body (Marshall, 2000). 
Like caramel (MacKenzie et al, 1992), CP had no adverse effect on the electrolytes 
of blood. 
Urinalysis test was mainly used to evaluate the renal function (Cavanaugh, 
1999). In the acute study, the 24-hour urine volumes in the control and treatment 
groups were similar. However, the total urine volume collected in 0.25% 
CP-exposed rats of the 6-month chronic treatment had significantly increased 
(p<0.05) (Figure 3.47). With the use of the dip-and-read urine test strips, the levels 
of several parameters were determined. This is economic, convenient and 
time-saving, although its aim is to provide a general information on the urine 
specimen. In this study, the urine specimen did not have any detectable differences. 
It again implies that the kidneys were functioning properly. 
Moreover, urine can provide information on hepatocellular damage. In urine 
of normal subjects, little urobilinogen is excreted by the kidneys. The urobilinogen 
is oxidized to urobilin which is a brown pigment. For those having haemolysis or 
hepatocellular diseases, an increased urobilinogen content will be found in their urine, 
which will then become deep orange-brown in color (Walmsley and White, 1994). 
Thus, the conduction of urinalysis test further proves that a high consumption of 
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CP in the acute test and a relatively low consumption of CP throughout a long period 
did not cause any adverse effect to the renal and hepatic systems of the rats. 
Macroscopic examination at the end of the acute and chronic toxicity tests did 
not reveal any lesions in the organs. Further microscopic studies on liver, kidney, 
thymus and testis showed no morphological changes as compared with the control 
group. Hence, these organs were not damaged by the application of CP. For 
caramel, thymi of AC-exposed rats demonstrated a decrease in cortical area, whereas 
the medullary area appeared to be enlarged (Houben et al., 1992). 
In the toxicological studies of CP, although there were some alternations found 
in the acute and 6-month chronic tests, no treatment-related clinical changes were 
observed on haematology, blood chemistry and urinalysis tests of the 9-month 
treatment, although a lower concentration of CP was used when compared to that of 
the acute test. This indicates that long term exposure to CP did not result in any 
、 harmful effects to the major organs such as heart, liver and kidneys. The rats 
adapted well to CP during the whole experimental period. This also implies that it 
is safe to humans for long-term consumption. 
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Chapter 5 Conclusion 
The Chinese chestnut is an economical plant cultivated in different regions of 
China. The chestnut shell is the non-edible part and is disposed of as agricultural 
waste. This study reports the preparation of a brown pigment CP from the shells 
which has a potential use as a natural food colorant. 
The CP is water soluble and is very stable. Autoclaving temperature (121°C) 
did not affect the pigment's absorbance spectrum. The color intensity of CP 
remained unchanged after a 12-month storage period under normal room lighting 
condition. These properties allow CP to be used in a wide variety of food items 
including canned food, bottled beverage, gravy, etc. 
Mutagenicity test indicated that CP is not genotoxic. In animal 
experimentation, results on the haematology, blood chemistry and urinalysis test 
showed that CP has no acute or chronic toxic effects on the tested rats. 
In addition to its coloring property, CP was also shown to have antioxidative 
activity. A 0.1% CP preparation exhibited antioxidative activity equivalent to 25 
m M B H A in the DPPH scavenging assay. This property further expands the 
pigment's potential application as a natural food preservative (antioxidant). 
Further studies on CP include structure analysis of the pigment molecule and 
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